===== DISCHARGE NOTE =====
note_id=13339096-DS-22 | hadm_id=20361095

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape ___ / Morphine
 
Attending: ___
 
Chief Complaint:
Abdominal pain-needs J tube placement
 
Major Surgical or Invasive Procedure:
___ tube placement
G-J tube placement

 
History of Present Illness:
___ MEDICINE ATTENDING ADMISSION NOTE .

 

Date: ___
 
Time: ___

_
________________________________________________________________

PCP: 
Name: ___ MD 
Address: ___ 
Phone: ___ 
Fax: ___ 
.
Name: ___ MD, MS 
Location: ___ OF GASTROENTEROLOGY/___ 
Address: ___, ___ 
Phone: ___ 
Fax: ___ 
Email: ___ 
.

. 

_
________________________________________________________________

 

HPI: 
___ year old female with a hstory of severe chronic pancreatitis 
with       associated abdominal pain and nausea. She had been 
recently on TPN  but developed a line infection and a flare of 
her pancreatitis. Had  recently been sent home on IV antibiotics 
tolerating a po diet. She has now completed the antibiotics but 
still unable to eat- unable to eat even sips of ensure. She 
reported pain, bloating and nausea when drinking ensure.  She 
reports the pain as being similar to the pain she always has 
when she has pancreatitis. ___ epigastric radiating as band 
around her abdomen. She was admitted for placement of a surgical 
J-tube.  

In ER: (Triage Vitals: 6 97.9 74 135/77 16 100 )
 Meds Given:  
Fluids given: 
Radiology Studies: CXR - PICCL in place per ED resident. 
consults called: surgery

.

PAIN SCALE: ___ pain even though patient was sound asleep when 
I entered the room and had to be awoken.

________________________________________________________________
REVIEW OF SYSTEMS:
CONSTITUTIONAL:        [] All Normal
[ ] Fever  [ ] Chills   [ ] Sweats  [ ] Fatigue   [ ] Malaise   
[ ]Anorexia  [ ]Night sweats
[+] __1___ lb.    weight  loss
HEENT:          [X] All Normal
[ ] Blurred vision   [ ] Blindness  [ ] Photophobia
[ ] Decreased acuity [ ] Dry mouth  [ ] Bleeding gums
[ ] Oral ulcers  [ ] Sore throat    [ ] Epistaxis  [ ] Tinnitus
[ ] Decreased hearing    [ ]Tinnitus [ ] Other:

RESPIRATORY:    [X] All Normal
[ ] SOB     [ ] DOE    [ ] Can't walk 2 flights     [ ] Cough
[ ] Wheeze  [ ] Purulent sputum    [ ] Hemoptysis   [ ]Pleuritic 
pain 
[ ] Other:

CARDIAC:        [X]  All Normal
[ ] Angina    [ ] Palpitations   [ ] Edema   [ ] PND
[ ] Orthopnea    [ ] Chest Pain [ ] Other:

GI:             [] All Normal
[ ] Blood in stool     [ ] Hematemesis     [ ] Odynophagia
[ ] Dysphagia:   [ ] Solids    [ ] Liquids
[ ] Anorexia    [+] Nausea  [] Vomiting   [ ] Reflux
[- ] Diarrhea    [-] Constipation  [+]  Abd pain  [ ] Other:

GU:             [X] All Normal
[ ] Dysuria      [ ] Frequency    [ ] Hematuria  []Discharge 
[]Menorrhagia  

SKIN:           [X] All Normal
[ ] Rash        [ ] Pruritus

MS:             [X] All Normal
[ ] Joint pain    [ ] Jt swelling   [ ] Back pain  [ ] Bony pain

NEURO:          [X] All Normal
[ ] Headache    [ ] Visual changes   [ ] Sensory change [ 
]Confusion [ ]Numbness of extremities
[ ] Seizures   [ ] Weakness [ ] Dizziness/Lightheaded [ ]Vertigo 
[ ] Headache

ENDOCRINE:     [X] All Normal
[ ] Skin changes  [ ] Hair changes   [ ] Temp subjectivity

HEME/LYMPH:    [X] All Normal
[ ] Easy bruising   [ ] Easy bleeding    [ ] Adenopathy

PSYCH:         [] All Normal
[ ?] some depression [-]Suicidal Ideation  [ ] Other:  

[X]all other systems negative except as noted above 
________________________________________________________________

 
Past Medical History:
1) Recurrent pancreatitis: Started after partial pancreatectomy  

in ___. Then not recurrent until ___. Was hospitalized in  
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
 
stent placement in panc duct. Further episodes in ___  
with same ERCP again and stent extension. In ___, another bout  

of acute pancreatitis, but ERCP this time showed no duct  
stenosis. ?in the past thought to be due to autoimmune, but did  

not improve with tx. Last admit, markers not suggestive.  
2) Hemolytic anemia: reaction to Keflex, treated with  
splenectomy in ___.  
3) s/p ccy in ___  
4) s/p appy in ___  
5) Asthma: mild intermittent, uses no meds at baseline  
6) hypothyroidism  
7) s/p tubal ligation  
8) Depression  
9) Right UE DVT in the setting of central line, on coumadin  
since ___, no longer on coumadin.
 
Social History:
___
Family History:
Father- lung cancer  
sister- ___  
Mother- osteoporosis, HTN, hypothyroidism, T2DM, chronic pain  

 
Physical Exam:
PHYSICAL EXAM: 

VITAL SIGNS: 

GLUCOSE: 

PAIN SCORE

VS; T = 98.7 P = 80 BP = 112/69 RR = 16 O2Sat 99% on RA 
GENERAL:  Well appearing female who appears to be her stated 
age. 
Nourishment: good  
Grooming: Well groomed  
Mentation: Alert, speaks in full sentences  
Eyes:NC/AT, PERRL, EOMI without nystagmus, no scleral icterus 
noted  
Ears/Nose/Mouth/Throat: MMM, no lesions noted in OP  
Neck: supple
Respiratory: Lungs CTA bilaterally without R/R/W  
Cardiovascular: RRR, nl. S1S2, soft ___ SEM at LUSB 
Gastrointestinal: soft, normoactive bowel sounds, epigastric 
tenderness, 
Genitourinary:  deferred
Skin: no rashes or lesions noted. PICCL insertion site C/D/I 
without erythema. Erythema present at the site of the tape. 
Extremities: No C/C/E bilaterally, 2+ radial, DP pulses b/l.  
Neurologic:  
-mental status: Alert, oriented x 3. Able to relate history 
without difficulty.  
-cranial nerves: II-XII intact  
-motor: normal bulk, strength and tone throughout. 
Psychiatric:  WNL

ACCESS: [X]PIV []CVL site ______

FOLEY: []present [x]none 

TRACH: []present [X]none  

PEG:[]present [X]none  [ ]site C/D/I 

COLOSTOMY: :[]present [X]none  [ ]site C/D/I 

 
Pertinent Results:
LABS: none drawn on admission
.

EKG: none on admission

OTHER DIAGNOSTICS: EGD/EUS ___
EUS
findings: EUS was performed using a linear echoendoscope at 7.5 
MHz frequency: The head and uncinate pancreas were imaged from 
the duodenal bulb and the second / third duodenum. The body and 
tail [partially] were imaged from the gastric body and fundus.  

Pancreas parenchyma: The entire pancreas showed the following 
parenchymal changes : lobularity, hyperechoic foci, and 
hyperechoic strands. The pancreas was small in volume [atrophic] 
throughout especially at the body of the pancreas. The head of 
the pancreas could not be fully examined due to patient's 
anatomy. 

Pancreas duct:The pancreas duct measured 4 mm in the head and 2 
mm in the body of the pancreas. The walls of the duct were 
hyperchoic. The duct was regular. Pancreatic parenchymal and 
duct changes taken together are suggestive of moderate severity 
chronic pancreatitis.  

The ampulla was examined. This showed changes c/w prior 
sphincterotomy. No other abnormalities were noted.  

Bile duct: moderate amount of air bubbles were noted in the bile 
duct, obscuring view. The duct in the porta-hepatis was normal. 
 
Impression: Pancreas parenchyma and duct showed changes c/w 
chronic pancreatitis. Ampulla showed post sphincterotomy 
changes, but was otherwise normal.  Limited images of bile duct 
and pancreatic duct were normal.
 
Recommendations: Follow-up with Dr. ___ in pancreas clinic.
Return patient to hospital ward. 

IMPRESSION: 
1. Successful placement of a ___ ___ tube via the 
greater 
curvature of the stomach and into the proximal jejunum. Of note, 
duodenum and proximal jejunum are all to the right of the 
midline due to this patient's partial pancreatectomy. 
2. Due to excessive air received by the patient for gastric 
insufflation over the last two days as well as receiving 
glucagon, which causes an ileus, an ileus of at least 24 hours, 
should be expected. Hence, tube usage should not be carried out 
for at least 24 hours after which feeding should be advanced 
slowly as tolerated. 
3. Two T-fasteners in place, these should be cut at the skin in 
approximately 14 days. 

 COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct 
___ 04:36    12.2* 3.54* 10.3* 30.8* 87 29.1 33.4 13.2 
415 
Source: Line-PICC 
DIFFERENTIAL Neuts Bands Lymphs Monos Eos Baso Atyps Metas 
Myelos 
___ 04:47    50 0 30 12* 6* 1 1* 0 0 

 
Brief Hospital Course:
The patient is a ___ year old woman with chronic pancreatitis s/p 
resection for pancreatic cyst who presented with inability to 
tolerate po intake. She had a recent PICC line infection placed 
for home TPN. Line was removed, a new one was placed and she 
finnished home IV antibiotics treatment. She was seen by Surgery 
in ED during this presentation who recommended a trial of 
nasojejunal (NJ) feeds to see if she tolerates it prior to 
planning either ___ guided ___ tube or open jejunostomy tube. ___ 
performed NJ tube insertion and she was started on NJ tube 
feeding at a rate of 15 ml per hour which was advanced to 45 ml 
per hour. She tolerated the NJ tube feeding very well without 
any complications. Case manager was unable to find ___ for her 
so she remained in the hospital until a G-J tube could be 
placed.  On the third attempt, ___ was successful on ___, and 
Tube feeds were restarted on ___.  Goal rate was advanced to 
cycling goal rate of 90ml/hr x 12hr overnight.  She tolerated 
this well without any residuals.  

She will need sutures removed and was instructed to follow up 
with her PCP ___ 2 weeks for this. She has followup with her PCP 
schedule per the discharge sheet.

She has followup with Dr. ___ in ___.

She will resume her outpatient medications.
 
Medications on Admission:
Fentanyl patch 100 mcg
Dilaudid 4mg q 4 hours
Senna
Colace
Synthyroid ___ mcg
Celexa 60 mg 
 
Discharge Medications:
1. fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr 
Transdermal Q72H (every 72 hours).  
2. citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
4. levothyroxine 75 mcg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily): take greater than ONE hour BEFORE starting night time 
tube feeds (i.e in the afternoon).  
5. clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 
hours) as needed for anxiety.
Disp:*21 Tablet(s)* Refills:*0*
6. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q6H (every 6 
hours) as needed for pain.  

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Chronic pancreatitis 
Chronic abdominal Pain
Moderate malnutrition
2 PICC line infections in past.

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for surgical or interventional radiology (___) 
guided placement of a tube placement in the jejunum (small 
bowel) but you ended up with a tube through your nose for entral 
(gastrointestinal) feeding trial before ___ gastric-jejunal (G-J) 
tube placement. Tube feedings were re started on ___ 
through this new G-J tube without complications and you 
tolerated your goal rate of 90mg/hr.  You will administer this 
for 12hr each night for you nutritional needs. You received tube 
feed pump education and feel competent to operate this. You were 
given contact information for Tube feed pump company nurse if 
you have questions.

You will need your sutures removed in 2 weeks time when you see 
your PCP. 

Please continue your regular oupatient regimen.  Any narcotic 
medication will be prescribed/renewed by your PCP.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-17 | hadm_id=22009329

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape / Morphine
 
Attending: ___.
 
Chief Complaint:
Abdominal pain.
 
Major Surgical or Invasive Procedure:
None.

 
History of Present Illness:
PCP: ___
GI: ___

This is a ___ yo woman with a history of chronic pancreatitis who 
presents with abdominal pain, nausea, vomitting c/w prior 
episodes of pancreatitis. She notes this started about 1 month 
ago, typical symptoms as prior episodes. She does not know what 
causes it, or what might have caused it this time. She also 
notes a 'flip flop' sensation in her mid epigastric area, that 
is new. Her pain is ___, radiating to her back on both sides. 
She denies fevers, dysuria, melena, hematochezia. She notes 
chronic constipation, last bm 4 days ago, which is normal for 
her, she uses fleets enemas prn. She has also noticed a restless 
leg sensation over the past week. She has lost about 5 lbs over 
the last month due to poor po intake but has been able to 
tolerate liquids. She has tried dilaudid 4mg po q4-6 at home 
with minimal relief of her symptoms. 

ROS: Chills for the past month, occasional headaches, 
generalized weakness/lethargy, otherwise extensive 10 point 
review of systems negative.
 
Past Medical History:
PMHx:
1) Recurrent pancreatitis: Started after partial pancreatectomy 
in ___.  Then no recurrent until ___.  Was hospitalized in 
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
stent placement in panc duct.  Further episodes in ___ 
with same ERCP again and stent extension.  In ___, another bout 
of acute pancreatitis, but ERCP this time showed no duct 
stenosis.  
2) Hemolytic anemia: reaction to Keflex, treated with 
splenectomy in ___.
3) s/p ccy in ___
4) s/p appy in ___
5) Asthma:  mild intermittent, uses no meds at baseline
6) hypothyroidism
7) s/p tubal ligation
8) Depression
 
Social History:
___
Family History:
Mother with diabetes, osteoporosis, hypertension, 
hypothyroidism, chronic pain
 
Physical Exam:
VS: T 99.4 HR 71 BP 121/78 RR 20 Sat 99% RA
Gen: Uncomfortable appearing woman in NAD
Eye: extra-occlar movements intact, pupils equal round, reactive 
to light, sclera anicteric, not injected, no exudates
ENT: mucus membranes moist, no ulcerations or exudates
Neck: no thyromegally, JVD: flat
Cardiovascular: regular rate and rhythm, normal s1, s2, no 
murmurs, rubs or gallops
Respiratory: Clear to auscultation bilaterally, no wheezes, 
rales or rhonchi
Abd: Soft, tender to palpation with guarding but no rebound in 
the epigastric area and bilateral upper quadrants, non 
distended, no heptosplenomegally, bowel sounds present
Extremities: No cyanosis, clubbing, edema, joint swelling
Neurological: Alert and oriented x3, CN II-XII intact, normal 
attention, sensation normal, asterixis absent, speech fluent, 
Integument: Warm, moist, no rash or ulceration  
Psychiatric: appropriate, pleasant
Hematologic: no cervical or supraclavicular LAD
 
Pertinent Results:
___: SBFT/UGI: Normal small bowel. Specifically, no 
small-bowel obstruction.  Small bowel malrotation with 
duodenojejunal flexure seen in the right upper quadrant. Mobile 
cecum. 
  
___: MRCP: 1. Mild intrahepatic and pancreatic ductal 
dilatation, similar to CT appearance from ___, however, 
increased from MRCP ___. Though the changing 
appearance of biliary system is unusual, the dilation of the 
pancreatic and biliary systems without a mass lesion raises the 
possibility of an ampullary stricture. 
2. Small bowel and pancreatic head malrotation. Stable changes 
status post 
distal pancreatectomy. Prompt emptying of the pancreatic duct 
following 
secretin administration. 

___ EUS: 
Findings: Esophagus: Normal limited exam of the esophagus. 
Stomach: Normal limited exam of the stomach. 
Duodenum: Normal limited exam of the duodenum. 

EUS:
findings: EUS was performed using a linear echoendoscope at 7.5 
MHz frequency: The head and uncinate pancreas were imaged from 
the duodenal bulb and the second / third duodenum. The body and 
tail [partially] were imaged from the gastric body and fundus.  

Pancreas parenchyma: The entire pancreas showed the following 
parenchymal changes : lobularity, hyperechoic foci, and 
hyperechoic strands. The pancreas was small in volume [atrophic] 
throughout especially at the body of the pancreas. The head of 
the pancreas could not be fully examined due to patient's 
anatomy. 

Pancreas duct:The pancreas duct measured 4 mm in the head and 2 
mm in the body of the pancreas. The walls of the duct were 
hyperchoic. The duct was regular. Pancreatic parenchymal and 
duct changes taken together are suggestive of moderate severity 
chronic pancreatitis.  

The ampulla was examined. This showed changes c/w prior 
sphincterotomy. No other abnormalities were noted.  

Bile duct: moderate amount of air bubbles were noted in the bile 
duct, obscuring view. The duct in the porta-hepatis was normal. 
 
Impression: Pancreas parenchyma and duct showed changes c/w 
chronic pancreatitis. Ampulla showed post sphincterotomy 
changes, but was otherwise normal. Limited images of bile duct 
and pancreatic duct were normal 

LABS:
___ 05:00PM   GLUCOSE-93 UREA N-14 CREAT-0.8 SODIUM-141 
POTASSIUM-4.3 CHLORIDE-105 TOTAL CO2-26 ANION GAP-14
___ 05:00PM   estGFR-Using this
___ 05:00PM   ALT(SGPT)-20 AST(SGOT)-29 ALK PHOS-81 
AMYLASE-49 TOT BILI-0.6
___ 05:00PM   LIPASE-47
___ 05:00PM   ALBUMIN-4.8 CALCIUM-9.8 PHOSPHATE-3.3 
MAGNESIUM-2.3
___ 05:00PM   WBC-13.5* RBC-4.23 HGB-13.0 HCT-38.1 MCV-90 
MCH-30.7 MCHC-34.0 RDW-12.8
___ 05:00PM   NEUTS-72.2* ___ MONOS-6.1 EOS-1.7 
BASOS-0.5
___ 05:00PM   PLT COUNT-480*
___ 05:40AM BLOOD WBC-9.8 RBC-3.53* Hgb-10.8* Hct-32.2* 
MCV-91 MCH-30.5 MCHC-33.5 RDW-12.8 Plt ___
___ 05:00AM BLOOD WBC-9.4 RBC-3.41* Hgb-10.4* Hct-31.4* 
MCV-92 MCH-30.4 MCHC-33.1 RDW-13.1 Plt ___
___ 05:30AM BLOOD WBC-8.6 RBC-3.49* Hgb-10.7* Hct-32.1* 
MCV-92 MCH-30.7 MCHC-33.3 RDW-12.7 Plt ___
___ 05:30AM BLOOD WBC-9.6 RBC-3.69* Hgb-11.3* Hct-33.8* 
MCV-92 MCH-30.6 MCHC-33.4 RDW-12.9 Plt ___
___ 05:00AM BLOOD WBC-7.8 RBC-3.43* Hgb-10.5* Hct-31.3* 
MCV-91 MCH-30.7 MCHC-33.7 RDW-13.1 Plt ___
___ 05:19AM BLOOD WBC-9.3 RBC-3.32* Hgb-10.0* Hct-30.5* 
MCV-92 MCH-30.3 MCHC-32.9 RDW-13.0 Plt ___
___ 05:45AM BLOOD WBC-9.2 RBC-3.43* Hgb-10.4* Hct-31.5* 
MCV-92 MCH-30.4 MCHC-33.2 RDW-12.9 Plt ___
___ 05:40AM BLOOD WBC-8.8 RBC-3.44* Hgb-10.4* Hct-32.0* 
MCV-93 MCH-30.1 MCHC-32.5 RDW-13.3 Plt ___
___ 05:40AM BLOOD Glucose-70 UreaN-12 Creat-0.7 Na-142 
K-3.9 Cl-110* HCO3-23 AnGap-13
___ 05:00AM BLOOD Glucose-73 UreaN-8 Creat-0.7 Na-143 K-4.4 
Cl-110* HCO3-26 AnGap-11
___ 05:30AM BLOOD Glucose-116* UreaN-4* Creat-0.8 Na-144 
K-4.3 Cl-107 HCO3-29 AnGap-12
___ 05:30AM BLOOD Glucose-71 UreaN-4* Creat-0.8 Na-142 
K-3.8 Cl-104 HCO3-29 AnGap-13
___ 05:00AM BLOOD Glucose-92 UreaN-4* Creat-0.7 Na-145 
K-4.2 Cl-107 HCO3-30 AnGap-12
___ 06:00AM BLOOD Glucose-81 UreaN-3* Creat-0.8 Na-143 
K-4.0 Cl-108 HCO3-29 AnGap-10
___ 06:00AM BLOOD Glucose-117* UreaN-5* Creat-0.7 Na-141 
K-4.2 Cl-106 HCO3-30 AnGap-9
___ 06:00AM BLOOD Glucose-74 UreaN-6 Creat-0.7 Na-146* 
K-4.5 Cl-108 HCO3-31 AnGap-12
___ 06:37AM BLOOD Glucose-101 UreaN-6 Creat-0.7 Na-144 
K-4.2 Cl-109* HCO3-29 AnGap-10
___ 05:19AM BLOOD Glucose-97 UreaN-9 Creat-0.7 Na-141 K-4.1 
Cl-105 HCO3-30 AnGap-10
___ 05:45AM BLOOD Glucose-92 UreaN-15 Creat-0.6 Na-138 
K-4.1 Cl-105 HCO3-27 AnGap-10
___ 05:40AM BLOOD Glucose-103 UreaN-14 Creat-0.7 Na-141 
K-4.3 Cl-108 HCO3-25 AnGap-12
___ 03:35PM BLOOD ALT-23 AST-29 AlkPhos-81 Amylase-48 
TotBili-0.6
___ 05:00PM BLOOD ALT-20 AST-29 AlkPhos-81 Amylase-49 
TotBili-0.6
___ 06:00AM BLOOD ALT-22 AST-25 AlkPhos-56 TotBili-0.3
___ 05:19AM BLOOD ALT-25 AST-33 AlkPhos-56 TotBili-0.4
___ 03:35PM BLOOD Lipase-47
___ 05:00PM BLOOD Lipase-47
___ 06:00AM BLOOD Lipase-71*
___ 06:37AM BLOOD Lipase-46
___ 05:19AM BLOOD Lipase-33
___ 05:45AM BLOOD Lipase-39
___ 05:00PM BLOOD Triglyc-97
___ 06:37AM BLOOD Triglyc-241*
___ 05:45AM BLOOD Triglyc-216*
___ 05:40AM BLOOD Free T4-0.96
___ 05:00PM BLOOD TSH-5.0*
___ 05:00AM BLOOD tTG-IgA-3
___ 05:00AM BLOOD IgA-___ yo woman with chronic pancreatitis admitted with likely acute 
pancreatitis flare.

1) Acute on chronic pancreatitis: There was no elevation of 
amylase and lipase initially, but her symptoms were consistant 
with her prior symptoms of acute pancreatitis. She had a 
sbft/ugi at the request of her gastroenterologist, Dr. ___, to 
r/o obstruction given h/o malrotation. This showed malrotation 
(known) but no acute functional abnormality. She then had an 
MRCP, which showed both hepatic and common bile duct dilation, 
but similar to prior imaging. She was evaluated by ERCP, but it 
was not thought that this would be helpful. She was treated 
symptomatically with iv dilaudid, ivf, and antiemetics. She was 
offered enteral feeding post-pyloric via dobhoff but declined 
this as she did not feel comfortable with the dobhoff. When 
restarting her oral diet she was recommended to have viokase 
with a ppi to replace pancreatic enzymes. Her pain regimen was 
changed to oral on ___, with addition of liquids. She had 
worsening of pain control with this. It is recommended that when 
she is able to tolerate food she take viokase with meals along 
with ppi or h2 blocker. After discussion of her case with Dr. 
___, her gastroenterologist, she warrants evaluation 
by Dr. ___ for consideration of repair of her 
malrotation, though her pain is not classically obstructive in 
nature, this will be done as an outpatient. She is also 
encouraged to undergo evaluation for spinal cord stimulation to 
help with pain control.  Anti TTG ab was 3 ___ normal range) 
and CRP was 1.8.

Unfortunately, she did not improve with oral diet.  After 
discussion with Dr. ___ on ___, she was initiated on TPN.  
PICC was placed, and TPN was initiated.  She then developed rt. 
UE edema and an u/s was done:

___ ___ F  ___  ___ 
 
Radiology Report UNILAT UP EXT VEINS US RIGHT Study Date of 
___ 10:09 AM 
 
  
___ 11R ___ 10:09 AM 
UNILAT UP EXT VEINS US RIGHT   Clip # ___   
Reason: ___ year old woman with pancreatitis, hx. DVT, has new 
picc l 
 

 
UNDERLYING MEDICAL CONDITION: 
   ___ year old woman with pancreatitis, hx. DVT, has new picc 
line rt. UE with  
   edema of arm - please eval for rt. UE DVT 
REASON FOR THIS EXAMINATION: 
   ___ year old woman with pancreatitis, hx. DVT, has new picc 
line rt. UE with  
   edema of arm - please eval for rt. UE DVT 

 
 
Provisional Findings Impression: YMf TUE ___ 11:37 AM 
PFI: Small nonocclusive thrombus in the right axillary vein. 

 
Final Report 
RIGHT UPPER EXTREMITY VENOUS ULTRASOUND 
  
INDICATION: ___ woman with pancreatitis, new right PICC 
line placed, 
presenting with new onset of right upper extremity edema. 
  
COMPARISON: Not available at the ___. 
  
FINDINGS: Gray-scale and color Doppler images of the right 
internal jugular, 
subclavian, axillary, brachial, and cephalic veins were 
obtained. There is a 
short segment of a nonocclusive thrombus in the right axillary 
vein. There is 
normal compressibility of the right internal jugular, 
subclavian, brachial, 
and cephalic veins. The right basilic PICC extends into the 
axillary, and 
subclavian vein. The right subclavian vein demonstrates 
decreased respiratory 
variability, which is due to combination of nonocclusive 
thrombus in the 
axillary vein as well as the presence of the intravenous 
catheter. 
  
IMPRESSION: Small nonocclusive thrombus in the right axillary 
vein. 
 
The picc line was removed and anticoagulation was initiated with 
unfractionated heparin and warfarin, transitioned to lovenox and 
warfarin with plans for conitinued outpatient monitoring of INR 
while undergoing lovenox bridge. 

She should be on lovenox until warfarin level therapeutic (___) 
for at least 48 hours.  Duration of anticoagulation to be 
determined by her primary MD, Dr. ___.

She was tolerating po diet (with abdominal pain, controlled by 
oral medications) on discharge and had stable vital signs.
 
Medications on Admission:
fentanyl duragesic patch 100
celexa 6mg daily
levothyroxine 137g daily
dilaudid 4mg po q4 prn pain
trazadone 100mg qhs
omeprazole 40mg daily
viokase 16 tid ac meals
naprosyn 500mg prn
compazine 10mg po prn nausea
 
Discharge Medications:
1. Fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr 
Transdermal Q72H (every 72 hours).  
2. Levothyroxine 137 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Citalopram 20 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
4. Amylase-Lipase-Protease 30,000-8,000- 30,000 unit Tablet Sig: 
Six (6) Tablet PO TID WITH MEALS ().
Disp:*540 Tablet(s)* Refills:*2*
5. Trazodone 100 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime) as needed for insomnia.  
6. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
Disp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*2*
7. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).
Disp:*60 Capsule(s)* Refills:*2*
8. Polyethylene Glycol 3350 100 % Powder Sig: One (1) packet PO 
DAILY (Daily) as needed for constipation.
Disp:*30 packets* Refills:*0*
9. Hydromorphone 4 mg Tablet Sig: One (1) Tablet PO every four 
(4) hours as needed for pain: do not drink alcohol or drive a 
car while taking this medication.
Disp:*100 Tablet(s)* Refills:*0*
10. Senna 8.6 mg Capsule Sig: One (1) Capsule PO twice a day.
Disp:*60 Capsule(s)* Refills:*2*
11. Warfarin 5 mg Tablet Sig: One (1) Tablet PO once a day.
Disp:*30 Tablet(s)* Refills:*0*
12. Enoxaparin 60 mg/0.6 mL Syringe Sig: One (1) syringe 
injection Subcutaneous Q12H (every 12 hours): until your 
coumadin level is therapeutic (between 2.0 and 3.0) for at least 
48 hours, then stop.
Disp:*20 syringe injection* Refills:*0*
13. Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO 
Q6H (every 6 hours) as needed for nausea.
Disp:*30 Tablet(s)* Refills:*0*
14. lab test  Sig: Five (5) lab tests, daily  once a day: 
___ lab test, daily for five days.  Fax result to Dr. 
___ at ___.
Disp:*5 lab test (blood draws)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Acute on chronic pancreatitis
VTE of rt. UE, catheter associated.

 
Discharge Condition:
Stable vital signs, on TPN, pain controlled with oral 
medications, taking lovenox injections and warfarin, tolerating 
po diet. 

 
Discharge Instructions:
You were admitted with acute pancreatitis in the setting of your 
chronic pancreatitis. You were treated with bowel rest and iv 
fluids and medications.  You did not tolerate restarting an oral 
diet, and you were started on TPN (intravenous feedings).  
Unfortunately, you developed a rt. upper extremitity blood clot 
(VTE), so the picc line was removed.  You will need to have 
lovenox injections twice daily until your coumadin level is 
therapeutic for at least 48 hours.  You will need to have your 
coumadin level checked daily for several days at your primary 
doctor's office.  I have informed them of this, and they are 
expecting you starting on ___ for your first blood 
test for your coumadin level.  You will need to take coumadin 
for at least three months, after which time you can discuss with 
Dr. ___ or not to stop taking coumadin.  As far as 
your abdominal pain is concern, Dr. ___ plans to arrange for 
spinal stimulation, however, you will need to have completed 
your course of anticoagulation with coumadin prior to this. 

Report to the nearest emergency room for any of the following:

shortness of breath
chest pain
lightheadedness
bleeding
blood in stools of vomitus.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-24 | hadm_id=22940841

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Morphine / Plastic tape
 
Attending: ___.
 
Chief Complaint:
Abdominal Pain
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ is a ___ year old woman with PMHx of chronic 
pancreatitis after partial pancreatectomy ___, multiple 
abdominal surgeries including splenectomy, appendectomy, CCY who 
presents with ___ dull epigastric pain and nausea. She reports 
that the pain has been going on for the last 2.5 weeks that 
feels like her usual pancreatitis pain. The pain is starts at 
the epigastric area, wraps around her upper abdomen "like a 
belt," radiates to her back and then up to the shoulder blades. 
She reports that it is the exact same her other bouts. She 
denies fevers, chills, sweats, recent illness, melena, 
hematochezia. She reports that she is having normal BMs. She 
reports that she has been taking Percocet 1 - 2 tabs per day, 
compazine, and has decreased rested her bowels by eating ensure, 
apple juice, and water. However, given that pain or nausea is 
not improving, she came to the ED for further evaluation. 

In the ED she had a CT that was unchanged and her lipase was not 
elevated. She was given pain control and admitted to the 
hospital for further eval and management. 

ROS: A 10 point ROS was conducted and was negative except as 
above. 
 
Past Medical History:
# recurrent pancreatitis: onset after partial pancreatectomy 
___, became recurrent ___ acute pancreatitis, ERCP with sphincterotomy and stent 
placement in pancreatic duct
- ___ acute episodes, ERCP with stent extension
- ___ acute pancreatitis, ERCP showed no duct stenosis
# hemolytic anemia: reaction to Keflex, treated with  
splenectomy ___.  
# s/p cholecystectomy ___  
# s/p appendectomy ___
# coagulase negative staphylococcus bacteremia secondary to PICC 
line infection ___
# RUE DVT secondary to central line ___, treated with warfarin
# ___ DVT & PE ___ post-op, treated with warfarin 
# rheumatoid arthritis (flares mostly in wrists & ankles)
# asthma: mild intermittent, URI-induced, rarely uses MDI
# hypothyroidism  
# s/p tubal ligation  ___
# depression / anxiety  

 
Social History:
___
Family History:
Father- lung cancer, died at age ___ in ___
sister- ___ 
Mother- osteoporosis, HTN, hypothyroidism, T2DM, chronic pain, 
alive

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
97.9, 137/78, 56, 16, 97%RA
GEN: NAD, laying in bed, pleasant
HEENT: MMM, EOMI, sclera anicteric
NECK: Supple
CV: RRR
RESP: CTAB
ABD: +BS, sfot, TTP in the upper quadrants bilaterally nad 
epigastrum, non-tender in the lower quadrants bilaterally
GU: No foley
SKIN: Warm and dry
EXT: No ___ pitting edema
NEURO: Fluent speech
PSYCH: Good insight, normal affect

 
Pertinent Results:
ADMISSION LABS:
___ 11:45PM BLOOD WBC-11.5* RBC-3.89* Hgb-12.0 Hct-36.0 
MCV-93 MCH-30.8 MCHC-33.3 RDW-13.0 RDWSD-44.0 Plt ___
___ 11:45PM BLOOD Neuts-65.4 ___ Monos-8.9 Eos-0.0* 
Baso-1.0 Im ___ AbsNeut-7.54* AbsLymp-2.82 AbsMono-1.02* 
AbsEos-0.00* AbsBaso-0.12*
___ 11:45PM BLOOD Glucose-139* UreaN-10 Creat-0.9 Na-139 
K-5.0 Cl-102 HCO3-24 AnGap-18
___ 11:45PM BLOOD ALT-15 AST-31 AlkPhos-98 TotBili-0.4
___ 11:45PM BLOOD Albumin-4.4 Calcium-9.8 Phos-4.2# Mg-2.1
___ 11:46PM BLOOD Lactate-1.1

___ 06:45AM BLOOD WBC-8.6 RBC-3.61* Hgb-11.2 Hct-34.0 
MCV-94 MCH-31.0 MCHC-32.9 RDW-13.0 RDWSD-44.5 Plt ___
___ 06:45AM BLOOD Glucose-125* UreaN-1* Creat-0.7 Na-139 
K-4.2 Cl-105 HCO3-25 AnGap-13
___ 06:45AM BLOOD Calcium-9.1 Phos-2.3* Mg-1.8
___ 11:46PM BLOOD Lactate-1.1

IMAGING:
FINDINGS:  
  
LOWER CHEST: Limited assessment of the lung bases demonstrates 
bilateral lower lobe atelectasis with left lower lobe 
bronchiectasis, unchanged since ___.  No mucous 
plugging. There is no evidence of pleural or pericardial 
effusion. 
  
ABDOMEN: 
  
HEPATOBILIARY: The liver demonstrates homogenous attenuation 
throughout.  
There is no evidence of focal lesions.  There is persistent mild 
intrahepatic biliary duct dilatation with the common bile duct 
measuring 12 mm (previously 12 mm) which is likely related to 
prior cholecystectomy and partial pancreatectomy.  The 
gallbladder is surgically absent with clips in the gallbladder 
fossa.  The portal vein and SMV are patent.  Status post 
hepaticojejunostomy.  The splenic vein has been resected. 
  
PANCREAS:  Patient is status post partial pancreatectomy with 
unchanged mild diffuse dilatation of the main pancreatic duct up 
to 4 mm  (previously 4 mm).  Minimal fat stranding around the 
pancreatic tail is stable. 
  
SPLEEN: Patient is status post splenectomy.  Again seen is a 5.8 
x 5.3 cm 
(previously 6 x 5 cm) accessory spleen.  No focal lesions. 
  
ADRENALS: The right and left adrenal glands are normal in size 
and shape. 
  
URINARY: The kidneys are of normal and symmetric size with 
normal nephrogram.  There is no evidence of focal renal lesions 
or hydronephrosis.  There is no perinephric abnormality. 
  
GASTROINTESTINAL: The stomach is unremarkable.  Patient is 
status post 
hepaticojejunostomy.  Patient's small bowel loops are along the 
right abdomen well ascending colon within the left abdomen, 
unchanged since prior examination.  Small bowel loops 
demonstrate normal caliber, wall thickness, and enhancement 
throughout.  The colon and rectum are within normal limits.  The 
appendix is not visualized, however no secondary signs of acute 
appendicitis. 
  
PELVIS: The urinary bladder and distal ureters are unremarkable. 
 There is no free fluid in the pelvis. 
  
REPRODUCTIVE ORGANS: The uterus is unremarkable.  No large 
adnexal masses 
seen. 
  
LYMPH NODES: There is no retroperitoneal or mesenteric 
lymphadenopathy.  There is no pelvic or inguinal 
lymphadenopathy. 
  
VASCULAR:  Therelationship of the SMA and SMV are reversed, 
nonspecific given the prior surgery.  There is no abdominal 
aortic aneurysm.  No atherosclerotic disease is noted. 
  
BONES: There is no evidence of worrisome osseous lesions or 
acute fracture. 
  
SOFT TISSUES: The abdominal and pelvic wall is within normal 
limits. 
  
IMPRESSION: 
  
  
1. Stable intra and extrahepatic biliary dilatation with mild 
pancreatic duct dilatation status post partial pancreatectomy, 
splenectomy, cholecystectomy, and hepaticojejunostomy. 
2. Findings suspicious for malrotation of bowel.  No 
obstruction. 
3. No acute intra-abdominal process to explain patient's 
symptoms. 

 
Brief Hospital Course:
___ year old woman with PMHx of chronic pancreatitis after 
partial pancreatectomy ___, multiple abdominal surgeries 
including splenectomy, appendectomy, CCY who presents with ___ 
dull epigastric pain and nausea consistent with past episodes of 
pancreatitis.
 
# Acute on Chronic Pancreatitis: Patient has gone several months 
since her last flare and it is unclear what triggers these 
flares.  She denies drinking.  She was hospitalized for six 
days, and on day four was able to start taking clears and by the 
time of discharge she was taking full liquids.  She was given 
Percocet tablet rx on discharge to manage her pain at home.   
She is quite knowledgeable about her condition and how to manage 
it (she has managed several flares at home).  She should f/u 
with her PCP and GI doctor ___.  

# Depression: Continued home Citalopram

# Hypothyroidism: Continued home  Levothyroxine

# Insomnia: Continued home trazodone

# Anxiety: Continued home lorazepam

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Citalopram 40 mg PO DAILY 
2. Levothyroxine Sodium 175 mcg PO DAILY 
3. Lorazepam 1 mg PO BID:PRN anxiety 
4. TraZODone 25 mg PO QHS:PRN insomnia 
5. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q6H pain 
6. Prochlorperazine 5 mg PO Q8H:PRN nausea 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
1.  Acute on chronic pancreatitis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to the hospital with abdominal pain due to a 
flare of your pancreatitis.  As before, you improved by not 
eating and by getting iv fluids and pain medications.  Slowly 
advance your diet at home and avoid fatty/spicy foods.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-23 | hadm_id=24511398

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Morphine / Plastic tape
 
Attending: ___.
 
Chief Complaint:
abd pain, pancreatitis
 
Major Surgical or Invasive Procedure:
EGD

 
History of Present Illness:
___ woman whose PMH includes RA, hypothyroidism, depression, 
s/p splenectomy ___ (as treatment of hemolytic anemia), 
cholecystectomy ___, pancreatic pseudocyst resection, recurrent 
pancreatitis as outlined below, attributed to sludge in CBD, 
last episode ___ (hospitalized here). Followed by GI Dr 
___ at ___. Does not have chronic pain, 
has been working and going to school. Developed gradual onset of 
epigastric pain which worsened over two weeks, assoc with nausea 
but no emesis. This is typical of her prior flares of 
pancreatitis. Pain became severe ___ so she presented to OSH 
ED, where lipase was 400, so she was transferred here for ERCP. 

In the ED, vitals were: Temp: 98.1 HR: 66 BP: 107/57 Resp: 15 O2 
Sat: 98% RA. She was given dilaudid 1mg IV x ___s 
zofran 4mg IV. On the medical floor, she reports good response 
to dilaudid given in ED. Has been eating small amounts because 
feels hungry, though food makes pain markedly worse. No F/C, CP, 
SOB, URI sx. No diarrhea, no hematochezia.  No fevers or chills, 
no CP, no SOB. ROS otherwise unremarkable.

 
Past Medical History:
# recurrent pancreatitis: onset after partial pancreatectomy 
___, became recurrent ___ acute pancreatitis, ERCP with sphincterotomy and stent 
placement in pancreatic duct
- ___ acute episodes, ERCP with stent extension
- ___ acute pancreatitis, ERCP showed no duct stenosis
# hemolytic anemia: reaction to Keflex, treated with  
splenectomy ___.  
# s/p cholecystectomy ___  
# s/p appendectomy ___
# coagulase negative staphylococcus bacteremia secondary to PICC 
line infection ___
# RUE DVT secondary to central line ___, treated with warfarin
# ___ DVT & PE ___ post-op, treated with warfarin 
# rheumatoid arthritis (flares mostly in wrists & ankles)
# asthma: mild intermittent, URI-induced, rarely uses MDI
# hypothyroidism  
# s/p tubal ligation  ___
# depression / anxiety  

 
Social History:
___
Family History:
Father- lung cancer, died at age ___ in ___
sister- ___ 
Mother- osteoporosis, HTN, hypothyroidism, T2DM, chronic pain, 
alive

 
Physical Exam:
EXAM: VS 98.1 107/55 61 96%RA
PAIN: 3 out of 10
GEN:   NAD, well-appearing
EYES:  conjunctiva clear anicteric
ENT:   dry mucous membranes
NECK:  supple
CV:    RRR s1s2 
PULM:  CTA
GI:    normal BS, ND, soft, mild epigastric tenderness
EXT:   warm, no edema, no joint effusions
SKIN:  no rashes
NEURO: alert, oriented x 3, answers ? appropriately, follows 
commands
PSYCH: appropriate, tearful when talking about her son
ACCESS: ___ 
FOLEY: none 

 
Pertinent Results:
___ 03:52AM   WBC-8.3 RBC-3.74* HGB-11.8* HCT-34.4* MCV-92 
MCH-31.5 MCHC-34.2 RDW-12.8
___ 03:52AM   NEUTS-55.9 ___ MONOS-8.0 EOS-2.6 
BASOS-1.0
___ 03:52AM   PLT COUNT-409
___ 03:52AM   GLUCOSE-109* UREA N-13 CREAT-0.9 SODIUM-141 
POTASSIUM-4.3 CHLORIDE-109* TOTAL CO2-25 ANION GAP-11
___ 03:52AM   ALT(SGPT)-37 AST(SGOT)-42* ALK PHOS-99 TOT 
BILI-0.2
___ 03:52AM   LIPASE-166*

CT ABDOMEN W & W/O CONTRAST ___:

COMPARISON:  CT abdomen and pelvis from ___
 
FINDINGS: 
There is dependent atelectasis and bronchiolectasis in the 
bilateral lower
lobes.  The previously described 5 mm nodule in the lateral 
right lower lobe
is not seen on the current study.
 
LIVER: The liver enhances homogeneously without a new focal 
lesion. The portal
vein is patent.Patient is status post cholecystectomy with 
surgical clips in
the gallbladder fossa. The common bile duct is dilated at the 
head of the
pancreas, up to 12 mm (14:16).  There is continued intra and 
extra hepatic
biliary dilatation, which is unchanged and nonspecific given the 
prior history
of cholecystectomy and partial pancreatectomy.  There is a tiny 
focus of
pneumobilia (12: 15).
 
SPLEEN: Patient is status post splenectomy. There is a 6.7 x 5.2 
cm splenule
in the left upper quadrant.
 
PANCREAS: Patient is status post partial pancreatectomy, with 
unchanged mild
diffuse dilation of the main pancreatic duct up to 4 mm (12:27).
 
ADRENALS: The adrenal glands are visualized and unremarkable.
 
KIDNEYS: The kidneys demonstrate symmetric nephrograms and 
excrete contrast
promptly. There is no focal lesion or hydronephrosis.
 
GI:The stomach is distended without obvious intraluminal mass or 
wall
thickening.The visualized portions of the small and large bowel 
are within
normal limits, without wall thickening or evidence of 
obstruction.  There is
an unremarkable hepaticojejunostomy.
 
RETROPERITONEUM: The aorta and common iliac vessels are normal 
in caliber,
with no significant atherosclerotic calcifications.  The left 
gonadal vein is
prominent, and may represent a persistent segment of the 
embryological left
IVC component (___). There is also an accessory left renal 
artery. There
is no retroperitoneal or mesenteric lymph node enlargement by CT 
size
criteria.
 
BONES: No focal lesion suspicious for malignancy.
 
IMPRESSION: 
 
1.  No significant change when compared to the CT from ___.
 
2. Persistent, unchanged intra and extrahepatic biliary 
dilatation and mild
pancreatic duct dilatation status post partial pancreatectomy, 
splenectomy,
cholecystectomy, and hepaticojejunostomy.
.
EGD:
Impression: Normal mucosa in the whole esophagus
Gastric deformity (biopsy)
Normal mucosa in the whole duodenum (biopsy)
Otherwise normal EGD to third part of the duodenum 
Recommendations: Nothing on this study to explain the patient's 
pain
Followup inpatient GI recs 

___ 07:20AM BLOOD WBC-9.7 RBC-3.38* Hgb-10.1* Hct-30.1* 
MCV-89 MCH-29.9 MCHC-33.5 RDW-13.8 Plt ___
___ 11:00AM BLOOD ALT-25 AST-26 AlkPhos-86 TotBili-0.7
___ 07:57AM BLOOD Lipase-___ woman whose PMH includes hypothyroidism, RA, depression, 
s/p splenectomy ___ to treat hemolytic anemia, s/p partial 
pancreatectomy and CCY ___, subsequent ERCPs. Has had recurrent 
pancreatitis attributed to biliary sludge, transferred from OSH 
for consideration of ERCP.

# recurrent acute pancreatitis: Has been previously attributed 
to biliary sludge s/p distant cholecystectomy and partial 
pancreatectomy. Currently there is no other clear etiology. Some 
prior notes have documented she has chronic pancreatitis, with 
last CT scan ___ reporting diffuse dilatation of the main 
pancreatic duct, but her overall clinical picture was not 
entirely consistent with chronic pancreatitis. CT scan of the 
abdomen was obtained and was unchanged from her last scan in 
___, which was when she was hospitalized for her last flare. 
She was clinically stable, tolerating clear liquid diet, but 
epigastric abdominal pain and nausea persisted. Case was 
discussed with ERCP team, who found no indication for another 
ERCP given clinical stability with unremarkable labs and 
unchanged CT scan. Given that EGD was unremarkable, pain 
attributed to her pancreas and she was started on pancreatic 
enzymes ___. She was started on a PPI. Her diet was advanced to 
clears ___ and regular low fat on ___. She will be following 
up with ___ her gastroenterologist and her PCP for 
ongoing care. She was prescribed a limited supply of dilaudid 
and advised not to take her already prescribed percocet. She was 
told to taper down and off her pain medications. She was 
prescribed zofran for nausea.

# epigastric pain: somewhat atypical location for pancreatitis. 
She remained stable with dilaudid for analgesia and zofran prn 
nausea. On ___ she had one episode of emesis, which was the 
first time she vomited since the onset of pain two weeks prior 
to admission. This was the only episode. Ddx included PUD/  
gastritis, especially in the setting of chronic NSAID use. She 
was started on PPI and given maalox prn dyspepsia. GI was 
consulted, and they recommended EGD. EGD on ___ was 
unremarkable. She was started on a PPI. Diet was advanced. See 
above.
.
#dyspnea/asthma-pt reported h.o asthma. After her EGD she felt 
SOB similar to prior asthma flares. She was not hypoxic, 
tachypneic nor did she have wheezing on exam. Symptoms improved 
with albuterol for which she was given a prescription upon 
discharge.
.
# RA: stable, no acute flare. NSAIDs were held. ___ advised to 
discuss use of NSAIDS with her rheumatologist.

# Chronic conditions were stable, and she was continued on her 
outpatient medications.

# multiple stressors, including traumatic death of her young 
son: Pt is well connected with PCP and therapist, and she is on 
an antidepressant & anxiolytic. SW was consulted and met with pt 
re coping and support.

# DVT PROPHYLAXIS: heparin sc
  
# CODE STATUS:     full code   

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Docusate Sodium 100 mg PO BID 
2. Citalopram 40 mg PO DAILY 
3. Levothyroxine Sodium 175 mcg PO DAILY 
4. Nabumetone 750 mg PO DAILY 
5. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain 
6. Lorazepam 1 mg PO BID:PRN anxiety 
7. TraZODone 25 mg PO QHS:PRN insomnia 

 
Discharge Medications:
1. Citalopram 40 mg PO DAILY 
2. Docusate Sodium 100 mg PO BID 
3. Levothyroxine Sodium 175 mcg PO DAILY 
4. Lorazepam 1 mg PO BID:PRN anxiety 
5. TraZODone 25 mg PO QHS:PRN insomnia 
6. Creon 12 3 CAP PO TID W/MEALS 
RX *lipase-protease-amylase [Creon] 12,000 unit-38,000 
unit-60,000 unit 3 capsule(s) by mouth TID with meals Disp #*270 
Capsule Refills:*0
7. HYDROmorphone (Dilaudid) ___ mg PO Q6H:PRN severe pain 
take as directed. do not drive 
RX *hydromorphone 2 mg ___ tablet(s) by mouth every 6 hours Disp 
#*15 Tablet Refills:*0
8. Nicotine Patch 14 mg TD DAILY Tobacco withdrawal 
RX *nicotine 14 mg/24 hour 1 patch daily Disp #*15 Patch 
Refills:*0
9. Pantoprazole 40 mg PO Q24H 
RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
10. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath 
RX *albuterol sulfate 90 mcg ___ puffs inhaled q6hrs Disp #*1 
Inhaler Refills:*0

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
# peptic ulcer disease/ gastritis
# recurrent pancreatitis
# chronic pancreatitis

secondary:
# rheumatoid arthritis
# depression
# hypothyroidism

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
please see below
You were admitted with abdominal pain due to pancreatitis. You 
were treated with medications and bowel rest. You were started 
on pancreatic enzymes. You had an EGD that was unrevealing and 
CT scan that was stable compared to your last one. Your diet was 
advanced to a regular, low fat diet.

You were prescribed a small supply of pain medication upon 
discharge. Please take this medication as prescribed with the 
goal of tapering it down to not requiring it anymore. Do not 
take this medication with percocet. Do not drive when taking 
this medication. Please take this medication with stool 
softeners. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-25 | hadm_id=25805125

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Morphine / Plastic tape
 
Attending: ___
 
Chief Complaint:
Admission for G-J tube placement 
 
Major Surgical or Invasive Procedure:
Gastro-jejunostomy tube placement

 
History of Present Illness:
___ with PMH of multiple episodes of pancreatitis now with 
chronic pancreatitis, hx of partial pancreatectomy ___, 
multiple abdominal surgeries including splenectomy, 
appendectomy, cholecystectomy. She has also had sphincterotomy 
and placement of a pancreatic stent. She has been ruled out for 
cystic fibrosis in ___. 

Because of her ongoing evidence of pain he she was placed on TPN 
in ___, then received a feeding tube for three months in ___. 
She did well for several years and now over the last four months 
she has recurrent discomfort with epigastric pain all the time. 

She was seen by Dr. ___ consideration of replacement of the 
feeding tube. He believed she had chronic pancreatitis and given 
her improvement with a feeding tube previously she was referred 
for placement of GJ feeding tube. She has this procedure done 
today and had no complications.

She is now complaining of dull pain. She is willing to try TFs 
tonight
  
ROS: per HPi, otherwise she denies fever, chills, night sweats, 
headache, vision changes, rhinorrhea, congestion, sore throat, 
cough, shortness of breath, chest pain, abdominal pain, nausea, 
vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, 
dysuria, hematuria
  

 
Past Medical History:
# Recurrent pancreatitis: onset after partial pancreatectomy 
___, became recurrent ___ acute pancreatitis, ERCP with sphincterotomy and stent 
placement in pancreatic duct
- ___ acute episodes, ERCP with stent extension
- ___ acute pancreatitis, ERCP showed no duct stenosis
# hemolytic anemia: reaction to Keflex, treated with  
splenectomy ___.  
# s/p cholecystectomy ___  
# s/p appendectomy ___
# coagulase negative staphylococcus bacteremia secondary to PICC 
line infection ___
# RUE DVT secondary to central line ___, treated with warfarin
# ___ DVT & PE ___ post-op, treated with warfarin 
# rheumatoid arthritis (flares mostly in wrists & ankles)
# asthma: mild intermittent, URI-induced, rarely uses MDI
# hypothyroidism  
# s/p tubal ligation  ___
# depression / anxiety  

 
Social History:
___
Family History:
Father- lung cancer, died at age ___ in ___
sister- ___ 
Mother- osteoporosis, HTN, hypothyroidism, T2DM, chronic pain, 
alive

 
Physical Exam:
ADMISSION PHYSICAL EXAM:
========================
VS:  97.8 130/70 77 18 94%RA
General: well appearing, obese, no acute distress
HEENT: PERRLA
Neck:  no LAD
CV:  RRR no murmurs
Lungs: CTAB/L no w/r/r
Abdomen: soft, tenderness over GJ site, tenderness in 
epigastrum, multiple well healed scars, GJ tube with erythema, 
no purulence, no rebound, no guarding
GU: no foley
Ext: no edema
Neuro: moving all extremities
Skin: no rashes

DISCHARGE PHYSICAL EXAM:
========================
VS: 98.2F  BP 128/61  HR 59  RR 18 99% RA 
General: well appearing, obese, no acute distress
HEENT: PERRLA, anicteric sclera
Neck:  no LAD, no pain, supple
CV:  RRR no murmurs
Lungs: CTAB/L no w/r/r
Abdomen: soft, mild tenderness in epigastrum, multiple well 
healed scars, GJ tube without erythema,no rebound, no guarding
Ext: no edema, warm and well perfused 
Neuro: moving all extremities
Skin: no rashes
 
Pertinent Results:
LABS:
======
___ 10:20AM BLOOD WBC-8.2 RBC-3.58* Hgb-11.1* Hct-34.1 
MCV-95 MCH-31.0 MCHC-32.6 RDW-12.9 RDWSD-45.0 Plt ___
___ 06:15AM BLOOD Glucose-93 UreaN-12 Creat-0.9 Na-137 
K-4.6 Cl-104 HCO3-21* AnGap-17
___ 06:05AM BLOOD Calcium-8.9 Phos-3.6 Mg-2.2

IMAGING:
========
Perc Jtube placement ___:
IMPRESSION:  
Successful placement of a 16 ___ ___ gastrojejunostomy 
tube with its tip in the proximal jejunum.  The tube is ready 
for immediate use as the lumen terminates in the jejunum. 
 
Brief Hospital Course:
___ with PMH of multiple episodes of pancreatitis now with 
chronic pancreatitis, hx of partial pancreatectomy ___, 
multiple abdominal surgeries including splenectomy, 
appendectomy, cholecystectomy who presents with inability to 
tolerate normal diet now s/p placement of GJ tube.

#Nutrition: Patient was at one point on TPN in ___ and also 
received G/J-tube feeds for a 3 month period in ___ Patient had 
successful placement of G-J tube. She had mild incisional 
tenderness, and post procedure vomiting, but felt improved 
during her hospital course. Patient was at risk for malnutrition 
due to chronic pancreatitis and recent decline in oral intake, 
but exhibited no recent weight loss over the past six months. 
She was seen by nutrition consultants who recommended starting 
tube feeds on standard formula, monitoring GI tolerance closely. 
Since patient was still eating orally, her tube feed regimen 
(Jevity 1.5) was set to meet ~75% of needs, then adjust as 
needed. She was started on Jevity 1.5 @ 10ml/hr and advanced by 
10ml/hr q4h to goal of 35ml/hr providing: 1260kcal, 54g protein, 
638ml free water 100ml free water flush q6h. For pain at site of 
incision, patient was requiring home Percocet along with IV 
Dilaudid (as patient fairly opioid tolerant), transitioned to PO 
dilaudid and discharged on a limited prescription. 

CHRONIC ISSUES:
================
#Hypothyroidism: continued home synthroid

#Anxiety/Psych: continued home SSRI and Ativan as needed 

Transitional Issues:
======================
-Discharge Tube feeds: Jevity at 35 cc/h with ___ 
-f/u with gastroenterology to determine if nutrition is 
appropriate
-Since patient is still eating orally, started with tube feed 
regimen meeting ~75% of needs, then adjust as needed. 
-Consider stool elastase to rule out fat malabsorption and 
checking 25(OH)vitamin D and other fat soluble vitamins
-Full code 
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Docusate Sodium 100 mg PO DAILY 
2. Citalopram 40 mg PO DAILY 
3. Levothyroxine Sodium 150 mcg PO DAILY 
4. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H:PRN pain 
5. Lorazepam 0.5 mg PO Q12H:PRN anxiety 

 
Discharge Medications:
1. Citalopram 40 mg PO DAILY 
2. Docusate Sodium 100 mg PO DAILY 
3. Levothyroxine Sodium 150 mcg PO DAILY 
4. Lorazepam 0.5 mg PO Q12H:PRN anxiety 
5. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q8H:PRN pain 
6. Nutrition
Jevity 1.5 @ 35ml/hr: 1260kcal, 54g protein, 638ml free water, 
100ml free water flush q6h, adjust PRN
Dispense 1 month supply, 2 refills 
7. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain 
RX *hydromorphone [Dilaudid] 4 mg 1 tablet(s) by mouth every 
four to six hours Disp #*20 Tablet Refills:*0

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis:
Chronic pancreatitis, need for tube feeds 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Ms. ___,

It was our pleasure caring for you at ___ 
___. You were admitted because of you difficulty with 
eating, due to your history of pancreatitis and abdominal pain. 
You had a feeding tube placed through your stomach into your 
intestines. You were given tube feeding and you did well. Please 
follow the tube feed eating plan.

Please keep your appointments below.

We wish you the best
Your ___ care team 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-20 | hadm_id=27161061

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape / Morphine
 
Attending: ___.
 
Chief Complaint:
abdominal pain
 
Major Surgical or Invasive Procedure:
___ line placement

 
History of Present Illness:
Pt is a ___ y.o female with h.o recurrent idiopathic 
pancreatitis, h.o hemolytic anemia s/p splenectomy, asthma, 
hypothyroidism, h.o RUE DVT, no longer on coumadin who presents 
with persistent abdominal pain, inability to tolerate enough PO, 
and weight loss. Pt reports that since discharge her abd pain 
has been ___ epigastric band like, squeezing and achy that 
can increase up to ___ after meals. Pt reports some nausea and 
1 episode of non-bloody, non-bilious vomiting. She denies 
constipation, diarrhea, melena, brbpr, dysuria, fever, chills. 
She states that she is only able to tolerate <1meal per day 
because of decreased appetite and that she has lost ___ over 
the last few weeks. She has been eating 'ding dongs' and candy.  
 
.
In addition, she denies fever, chills, headache, dizziness, LH, 
ST/URI/cough, CP, SOB, palp, paresthesias, weakness, rash, 
heat/cold intolerance. Pt presented to GI clinic today and was 
advised to present for admission to start TPN.
 
Past Medical History:
1) Recurrent pancreatitis: Started after partial pancreatectomy 
in ___.  Then no recurrent until ___.  Was hospitalized in 
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
stent placement in panc duct.  Further episodes in ___ 
with same ERCP again and stent extension.  In ___, another bout 
of acute pancreatitis, but ERCP this time showed no duct 
stenosis. ?in the past thought to be due to autoimmune, but did 
not improve with tx. Last admit, markers not suggestive.
2) Hemolytic anemia: reaction to Keflex, treated with 
splenectomy in ___.
3) s/p ccy in ___
4) s/p appy in ___
5) Asthma: mild intermittent, uses no meds at baseline
6) hypothyroidism
7) s/p tubal ligation
8) Depression
9) Right UE DVT in the setting of central line, on coumadin 
since ___, no longer on coumadin.
 
Social History:
___
Family History:
Mother with diabetes, osteoporosis, hypertension, 
hypothyroidism, chronic pain.
Others with Crohns, diverticulitis, lung ca
 
Physical Exam:
gen-well appearing, walking around her room, NAD
vitals- 
heent-nc/at, eomi, anicteric, MMM, no oP lesions
neck-supple, no lad, no JVD
chest-b/l ae no w/c/r
heart-s1s2 rrr no m/r/g
abd-+bs, +well healed large abd scar from prior splenectomy, 
+TTP, epigastric area, LUQ, neg ___ sign, no guarding or 
rebound
ext-no c/c/e 2+pulses
neuro-aaox3, CN2-12 intact, motor ___ x4, sensation equal and 
intact to LT, no tremor
psych-calm, appropriate, no SI
 
Pertinent Results:
.
MRCP ___
IMPRESSION: 
1. Mild intrahepatic and pancreatic ductal dilatation, similar 
to CT 
appearance from ___, however, increased from MRCP ___. Though the changing appearance of biliary system is 
unusual, the dilation of the pancreatic and biliary systems 
without a mass lesion raises the possibility of an ampullary 
stricture. 
2. Small bowel and pancreatic head malrotation. Stable changes 
status post 
distal pancreatectomy. Prompt emptying of the pancreatic duct 
following 
secretin administration. 
.
ca ___ last admit-normal
 .
___ 05:38AM BLOOD WBC-9.6 RBC-3.52* Hgb-10.5* Hct-32.0* 
MCV-91 MCH-29.7 MCHC-32.7 RDW-13.4 Plt ___
___ 08:30AM BLOOD WBC-9.0 RBC-3.57* Hgb-11.0* Hct-32.6* 
MCV-91 MCH-30.8 MCHC-33.8 RDW-13.4 Plt ___
___ 01:10AM BLOOD WBC-8.4 RBC-3.41* Hgb-10.6* Hct-30.9* 
MCV-91 MCH-31.0 MCHC-34.2 RDW-13.7 Plt ___
___ 05:25AM BLOOD WBC-8.8 RBC-3.30* Hgb-10.3* Hct-29.7* 
MCV-90 MCH-31.4 MCHC-34.8 RDW-13.3 Plt ___
___ 09:00PM BLOOD WBC-9.3 RBC-3.68* Hgb-10.9* Hct-33.1* 
MCV-90 MCH-29.7 MCHC-33.0 RDW-12.4 Plt ___
___ 05:38AM BLOOD Plt ___
___ 08:30AM BLOOD Plt ___
___ 05:25AM BLOOD Plt ___
___ 09:00PM BLOOD Plt ___
___ 05:38AM BLOOD Glucose-111* UreaN-15 Creat-0.7 Na-138 
K-4.6 Cl-104 HCO3-28 AnGap-11
___ 06:00AM BLOOD Glucose-107* UreaN-13 Creat-0.7 Na-138 
K-4.4 Cl-103 HCO3-30 AnGap-9
___ 01:10AM BLOOD Glucose-120* UreaN-8 Creat-0.5 Na-139 
K-4.1 Cl-103 HCO3-30 AnGap-10
___ 05:25AM BLOOD Glucose-99 UreaN-5* Creat-0.6 Na-141 
K-4.2 Cl-109* HCO3-29 AnGap-7*
___ 09:00PM BLOOD Glucose-128* UreaN-6 Creat-0.6 Na-138 
K-4.1 Cl-104 HCO3-30 AnGap-8
___ 09:00PM BLOOD ALT-12 AST-21 LD(LDH)-123 AlkPhos-92 
TotBili-0.2
___ 09:00PM BLOOD Lipase-59
___ 05:38AM BLOOD Calcium-9.1 Phos-3.7 Mg-2.3
___ 06:00AM BLOOD Calcium-9.0 Phos-4.3 Mg-2.2
___ 01:10AM BLOOD Calcium-8.9 Phos-4.1 Mg-2.1
___ 05:25AM BLOOD Calcium-8.5 Phos-3.6 Mg-1.9
___ 09:00PM BLOOD Albumin-4.1 Calcium-9.1 Phos-3.5 Mg-2.0
___ 05:38AM BLOOD Triglyc-299*
___ 05:25AM BLOOD Triglyc-257*
___ 05:25AM BLOOD TSH-7.1*
___ 12:35PM BLOOD T4, FREE, DIRECT DIALYSIS-PND
.
___ HISTORY: PICC placement. 
FINDINGS: The tip of the PICC line now lies within the lower 
portion of the SVC. No acute cardiopulmonary disease. 
.
___ CXR:SINGLE AP PORTABLE VIEW OF THE CHEST 
  
REASON FOR EXAM: Assess line.  
Left PICC tip is in the right atrium, should be withdrawn 
approximately 4 cm for a standard positioning. Cardiomediastinal 
contours are normal. The lungs are clear. There is no 
pneumothorax or pleural effusion. 
The study and the report were reviewed by the staff radiologist. 


  

 
Brief Hospital Course:
Assessment/Plan:  
Pt is a ___ y.o female with h.o idiopathic pancreatitis, s/p 
splenectomy for hemolytic anemia, hypothyroidism, h.o RUE DVT 
after CVL, depression who presents with continued abdominal 
pain, weight loss, and inability to tolerate PO. 
.  
#chronic pancreatitis-Pt with h.o partial pancreatectomy for 
pancreatitic cyst in the past with post procedure pancreatitis. 
Work up for etiology has not revealed a cause. At one time, 
there was consideration of autoimmune etiology and treatment for 
this, but pt symptoms did not improve. ___ 1:40 last 
admit/immunoglobulins normal. Pt reports continued abd pain with 
same quality and character as last admission, but does report 
only able to tolerate <1meal per day with some snacks due to 
decreased appetite. She reported ___ weight loss over last 
few weeks. Pain was stable and unchanged. LFTs/lipase normal. 
Given pt's symptoms at home, Pt's gastroenterologist Dr. ___ 
___ for the patient to be admitted to the hospital for the 
initiation of TPN. Pt was continued on her home regimen of PO 
dilaudid ___ Q4hrs and fentanyl patch 100mcg every 72hrs for 
pain control. She was given compazine for nausea prn. PICC line 
was placed upon admission, however single lumen was placed 
instead of a double lumen and this was then changed on ___. 
CXR confirms appropriate placement. Pt started TPN on ___. 
Nutrition was consulted who provided the patient's daily TPN 
recommendations. Pt tolerated TPN and cycling this admission. 
She will have weekly CBC, chem 10, and LFTs followed by ___ 
___, RD and Dr. ___ ___ tele 
___ upon discharge:
volume(ml/d) Amino Acid(g/d) Dextrose(g/d) Fat(g/d) 
1675            70              280         35
Trace Elements will be added daily 
Standard Adult Multivitamins 
NaCL NaAc NaPO4 KCl KAc KPO4 MgS04 CaGluc 
70    0    20   40  0     0   10      9 
___ will continue to follow up with her gastroenterologist Dr. 
___ further work up and treatment of her pancreatitis. She 
should discuss the need for pancreatic enzyme supplementation 
with her GI doctor as well.
Cycle over (hrs.) Start at Decrease rate to (ml/h) at Stop at 
12 1800 0 0600 0600 
.  
#hypothyroidism- continued home regimen levothyroxine 150mcg 
daily. TFT's checked last admit and adjusting medication was 
deferred to the outpatient setting when not hospitalized. TSH 7 
this admission. Free T4 still pending at time of discharge. Pt 
admitted to not taking her synthroid at home in a few weeks. She 
was advised to take this medication daily and follow up with her 
PCP for adjustment as needed.  
.  
#normocytic anemia-baseline ___. Last iron studies showed 
anemia of chronic disease. Pt is S/p splenectomy for hemolytic 
anemia in the past. HCT trended and remained stable. Stools were 
guaiaced. Pt can discuss with her PCP the need for outpatient 
colonoscopy.  
.  
#thrombocytosis-This was thought to be reactive. Pt did not have 
fever, leukocytosis or localizing symptoms to suggest infection. 
Resolved.  
.  
#depression-no SI, pt continued on  outpatient regimen of celexa 
60mg daily  
.  
#h.o RUE DVT-related to CVL. Finished tx course in ___ per 
report.  
.  
#FEN-regular diet, nutrition consult. TPN 
.  
#ppx-hep sc, bowel reg  
.  
#access-PIV, PICC.   
.  
#code-full  
.  
.  

 
Medications on Admission:
celexa 60mg PO daily
Hydromorphone 4 mg  PO Q4hr PRN
Levothyroxine 150 mcg PO daily
Docusate Sodium 100 mg  PO BID 
Senna 8.6 mg Two Tablet PO BID
fentanyl patch 100mcg/hr Q3 days 
 

 
Discharge Medications:
1. levothyroxine 150 mcg Tablet Sig: One (1) Tablet PO once a 
day.  
2. fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr 
Transdermal Q72H (every 72 hours).  
3. citalopram 20 mg Tablet Sig: Three (3) Tablet PO once a day.  

4. senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day.  
5. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.  
6. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q4H (every 4 
hours) as needed for severe pain.  
7. prochlorperazine maleate 5 mg Tablet Sig: One (1) Tablet PO 
Q6H (every 6 hours) as needed for nausea.  
8. Outpatient Lab Work
weekly CBC, chem 10, lfts. 
Please fax results ___, RD and Dr. ___ 
___ tele ___.

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Major:
chronic idiopathic pancreatitis
weight loss
nausea
 
minor: hypothyroidism, depression, anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for the initiation of TPN due to poor food 
intake at home related to your chronic pancreatitis. You had a 
PICC line placed without complication. You were started on TPN 
without  complication. You will go home on TPN and an infusion 
company has been set up. You should have your labs monitored 
weekly and Dr. ___ decide the plan for further care and 
duration of your TPN as well as any further work up for your 
pancreatitis.
.
You have a mild anemia. Please discuss with your PCP whether you 
may need a colonoscopy.
.
Medication changes:
none.
.
Please follow up with the appointments below and take all of 
your medications as prescribed.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-16 | hadm_id=27195207

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape
 
Attending: ___
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
EGD
PICC line placement ___

 
History of Present Illness:
This is a ___ year-old female with a history of recurrent 
pancreatitis who presents with abdominal pain and nausea 
consistent with her prior presentations.  She is normally able 
to manage her pancreatitis flares at home with PRN percocet and 
compazine but could not tolerate it any further, so she came in.

In the ED, initial vitals were T:98.9 BP:102/47 HR:56 RR:14 
O2Sat:97% on RA.  She received hydromorphone and ondansetron 
with some relief of her symptoms.  Shw hD ___ abdominal 
epigastric pain and some residual nausea.
  
ROS: The patient denies any fevers, chills, weight change, 
nausea, vomiting, abdominal pain, diarrhea, constipation, 
melena, hematochezia, chest pain, shortness of breath, 
orthopnea, PND, lower extremity oedema, cough, urinary 
frequency, urgency, dysuria, lightheadedness, gait unsteadiness, 
focal weakness, vision changes, headache, rash or skin changes.  

 
Past Medical History:
PMHx:
1) Recurrent pancreatitis: Started after partial pancreatectomy 
in ___.  Then no recurrent until ___.  Was hospitalized in 
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
stent placement in panc duct.  Further episodes in ___ 
with same ERCP again and stent extension.  In ___, another bout 
of acute pancreatitis, but ERCP this time showed no duct 
stenosis.  
2) Hemolytic anemia:  reaction to Keflex, treated with 
splenectomy in ___.
3) s/p ccy in ___
4) s/p appy in ___
5) Asthma:  mild intermittent
6) hypothyroidism
7) s/p tubal ligation
 
Social History:
___
Family History:
Negative for GI illnesses. 
Positive for lung CA, cervical CA. 
 
Physical Exam:
Vitals: T:99.4 BP:108/74 HR:76 RR:16 O2Sat:99%  
GEN: Well-appearing, well-nourished, no acute distress  
HEENT: EOMI, PERRL, sclera anicteric, no epistaxis or 
rhinorrhea, MMM, OP Clear  
NECK: No JVD, carotid pulses brisk, no bruits, no cervical 
lymphadenopathy, trachea midline  
COR: RRR, no M/G/R, normal S1 S2, radial pulses +2  
PULM: Lungs CTAB, no W/R/R  
ABD: Soft, + epigastric tenderness to palpation , ND, +BS, no 
HSM, no masses, scars from splenectomy and pancreatitic 
pseudocyst/appendix/gall bladder surgery.
EXT: No C/C/E, no palpable cords  
NEURO: alert, oriented to person, place, and time. CN II  XII 
grossly intact. Moves all 4 extremities. Strength ___ in upper 
and lower extremities.
 
Pertinent Results:
___ 
WBC-6.5 RBC-4.30# Hgb-13.0 Hct-38.9 MCV-90 MCH-30.3 MCHC-33.5 
RDW-12.6 Plt ___ ___ Monos-6.8 Eos-4.3* 
Baso-1.2
Glucose-104 UreaN-9 Creat-0.9 Na-139 K-4.5 Cl-103 HCO3-27 
AnGap-14

___ 
WBC-13.5* RBC-3.48* Hgb-11.0* Hct-31.9* MCV-92 MCH-31.5 
MCHC-34.4 RDW-12.6 Plt ___
Neuts-58.8 ___ Monos-8.4 Eos-3.8 Baso-0.9
___ PTT-41.3* ___
Glucose-115* UreaN-16 Creat-0.6 Na-139 K-4.3 Cl-107 HCO3-25 
AnGap-11

___ 04:45PM BLOOD ALT-13 AST-23 AlkPhos-74 Amylase-68 
TotBili-0.5 Lipase-55
___ Amylase-48 Lipase-43
___ ALT-33 AST-29 AlkPhos-78 TotBili-0.7
___ Amylase-31 Lipase-32

___ 05:50AM BLOOD Calcium-8.5 Phos-2.9# Mg-2.0
___ 06:05AM BLOOD Calcium-8.7 Phos-3.5 Mg-2.0
___ 05:35AM BLOOD Triglyc-95 HDL-33 CHOL/HD-4.2 LDLcalc-88
___ 06:05AM BLOOD Triglyc-206*

___ 02:13PM URINE 
___ WBC->50 Bacteri-FEW Yeast-NONE ___
URINE CULTURE (Final ___: 
      ESCHERICHIA COLI.    >100,000 ORGANISMS/ML.. 
         PRESUMPTIVE IDENTIFICATION. 
Pansensitive.

AXR ___: Nonobstructive bowel gas pattern. No free air.

Abdominal CT ___:
1. Mild stranding adjacent to the distal aspect of the remaining 
pancreas, probably related to pancreatitis. There is no evidence 
of pseudocyst, fluid collection or pancreatic necrosis.  
2. Intra- and extra-hepatic bile duct dilation and pancreatic 
ductal dilation appears similar to the recent MRCP of ___, 
but these ducts are increased in caliber compared to the prior 
CTA of ___. This raises the possibility of papillary 
stenosis. 

___ EGD
Findings: Esophagus:  
 Mucosa: Normal mucosa was noted.  
Stomach:  
 Protruding Lesions A single 3mm polyp of benign appearance was 
found in the proximal stomach body. A cold forceps biopsy was 
performed for histology.  
Duodenum:  
 Mucosa: Normal mucosa was noted.  

Impression: Polyp in the proximal stomach body (biopsy)
Otherwise normal EGD to third part of the duodenum 

___ Pathology
Gastric proximal body, mucosal biopsy:
Body-type mucosa with focal mild chronic inflammation and a few 
dilated glands consistent with fundic gland polyp.

 
Brief Hospital Course:
1) Abdominal pain: Her presentation was felt most consistent 
with a pancreatitis flare, without rise in biochemical markers. 
Her symptoms improved without eating for several days and then 
worsened after trying to advance from clear to full liquids. She 
additionally reported nausea, which improved with empiric PPI 
therapy. Given her protracted symptoms, GI was consulted. A CT 
scan of the abdomen with pancreas protocol on ___ showed 
peripancreatic stranding and ducts similar in size to previous 
MRCP but dilated compared to previous CTA. An EGD was 
additionally performed, and did not disclose other pathology 
(polyp biopsied). In light of poor nutritional intake and 
failure to advance her diet, TPN was recommended. A PICC line 
was placed on (___). She tolerated the TPN and reached her goal 
per nutrition recommendations. She was discharged after cycling 
down her TPN to 18 hours, her goal at home was set to 12 hrs. 
She was setup with ___ for her TPN and will follow up with her 
PCP and GI within one week.

2) Asthma: Did not require treatment during this admission.

3) Depression: Stable, continued on citalopram

4) Hypothyroidism: Stable continued on levothyroxine 75mcg 
daily.

5) Tobacco abuse: Pt was started on NicoDerm Patch and will 
continue after discharge.

 
Medications on Admission:
Levothyroxine 75mcg daily  
Citalopram 40mg daily  
Percocet prn
Compazine PRN pancreatitis  

 
Discharge Medications:
1. Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 
 
2. Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Nicotine 21 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr 
Transdermal DAILY (Daily).
Disp:*30 Patch 24 hr(s)* Refills:*2*
4. Ursodiol 300 mg Capsule Sig: One (1) Capsule PO BID (2 times 
a day).
Disp:*60 Capsule(s)* Refills:*2*
5. Compazine 5 mg Tablet Sig: One (1) Tablet PO every six (6) 
hours as needed for nausea.
Disp:*60 Tablet(s)* Refills:*0*
6. Dilaudid 4 mg Tablet Sig: One (1) Tablet PO every ___ hours 
as needed for pain.
Disp:*126 Tablet(s)* Refills:*0*
7. Senna 8.6 mg Tablet Sig: One (1) Tablet PO twice a day as 
needed for constipation.
Disp:*60 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Primary:
Acute flare of chronic pancreatitis

Secondary:
Asthma
Depression
Urinary tract infection
 
Discharge Condition:
Stable, normotensive, afebrile, good O2 sats on Room air, 
tolerating clear liquids, ambulating

 
Discharge Instructions:
It was a pleasure taking care of you while you were in the 
hospital.  You have been diagnosed with chronic pancreatitis.  A 
CT was performed that was consistent with pancreatitis.  You 
also had an EGD which only showed inflammation and a fundic 
gland polyp.  You were evaluated by nutrition and will require 
long term total parenteral nutrition. 
***
You should follow up with your PCP who will check your labs 
weekly.  Additionally, you will have ___ services for your TPN 
administration.
***
Please take all of your medications exactly as prescribed, 
including your TPN.
Please follow up with the appointments below.
***
Please call your PCP or go to the ED if you experience worsening 
abdominal pain, nausea, vomiting, urinary problems, fevers, 
chills, shortness of breath or other concerning symptoms. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-21 | hadm_id=27779956

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape ___ / Morphine
 
Attending: ___.
 
Chief Complaint:
Abdominal pain
 
Major Surgical or Invasive Procedure:
PICC line insertion ___

 
History of Present Illness:
___ year old woman with chronic pancreatitis. She was placed on 
TPN this past ___. She had reportedly been doing much better, 
but did have occasional flares. Over the last couple of days she 
started having a classic flare with pain in the epigastric area 
radiating around to the back. It is made worse with sips and 
laying down flat. She had one episode of diarrhea yesterday. She 
has also had intermittent nausea.  
.  
In the ED, she was given IVF and IV dilaudid. Her pain improved 
from a 7 to a 6.  
.  
ROS: Patient notes she had a temp of 100.1 on ___. She has 
some nasal congestion, but otherwise feels well. Denies sore 
throat, cough, shortness of breath, chest pain, vomiting, 
constipation, BRBPR, melena, hematochezia, dysuria, hematuria. 
She was recently with her young granchildren, but no known sick 
contacts.
 
Past Medical History:
1) Recurrent pancreatitis: Started after partial pancreatectomy  

in ___. Then not recurrent until ___. Was hospitalized in  
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
 
stent placement in panc duct. Further episodes in ___  
with same ERCP again and stent extension. In ___, another bout  

of acute pancreatitis, but ERCP this time showed no duct  
stenosis. ?in the past thought to be due to autoimmune, but did  

not improve with tx. Last admit, markers not suggestive.  
2) Hemolytic anemia: reaction to Keflex, treated with  
splenectomy in ___.  
3) s/p ccy in ___  
4) s/p appy in ___  
5) Asthma: mild intermittent, uses no meds at baseline  
6) hypothyroidism  
7) s/p tubal ligation  
8) Depression  
9) Right UE DVT in the setting of central line, on coumadin  
since ___, no longer on coumadin.
 
Social History:
___
Family History:
Father- lung cancer  
sister- ___  
Mother- osteoporosis, HTN, hypothyroidism, T2DM, chronic pain  

 
Physical Exam:
VS: 98.6 101 128/88 16 100 RA  
GENERAL - sitting upright in bed covered in blankets  
HEENT - NC/AT, pupils equal, sclerae anicteric, MMM  
LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored 
 
HEART - RR, no MRG, nl S1-S2  
ABDOMEN - soft/ND, tenderness to palpation in epigastric area 
and L>R upper quadrants  
EXTREMITIES - WWP, 2+ peripheral pulses, left sided PICC  
SKIN - no rashes or lesions  
NEURO - awake, A&Ox3  

 
Pertinent Results:
Admission labs:
___ 11:45PM BLOOD WBC-13.3* RBC-4.10* Hgb-12.1 Hct-35.7* 
MCV-87 MCH-29.6 MCHC-34.0 RDW-13.0 Plt ___
___ 11:45PM BLOOD Neuts-65.3 ___ Monos-6.6 Eos-1.6 
Baso-0.9
___ 11:45PM BLOOD Glucose-88 UreaN-14 Creat-0.7 Na-137 
K-4.0 Cl-104 HCO3-23 AnGap-14
___ 11:45PM BLOOD ALT-17 AST-26 AlkPhos-91 TotBili-0.4
___ 11:45PM BLOOD Albumin-4.5 Cholest-132
.
Other labs:
___ 06:45AM BLOOD ___ PTT-29.4 ___
___ 05:00AM BLOOD ___ PTT-33.0 ___
___ 06:45AM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL
___ 12:45PM BLOOD Hypochr-NORMAL Anisocy-NORMAL 
Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL 
Ovalocy-OCCASIONAL
___ 05:00AM BLOOD ESR-28*
___ 11:45PM BLOOD Triglyc-104 HDL-34 CHOL/HD-3.9 LDLcalc-77
___ 06:45AM BLOOD CRP-10.3*
___ 07:25AM BLOOD Vanco-12.5
___ 06:17AM BLOOD Vanco-21.8*
___ 06:35AM BLOOD Vanco-27.2*
___ 11:56PM BLOOD Lactate-1.0
___ 01:09PM BLOOD Lactate-1.2
.
WBC trend
___ 11:45PM BLOOD WBC-13.3* RBC-4.10* Hgb-12.1 Hct-35.7* 
MCV-87 MCH-29.6 MCHC-34.0 RDW-13.0 Plt ___
___ 06:45AM BLOOD WBC-28.0*# RBC-3.92* Hgb-11.5* Hct-34.7* 
MCV-89 MCH-29.3 MCHC-33.0 RDW-13.1 Plt ___
___ 12:45PM BLOOD WBC-32.2* RBC-3.63* Hgb-11.0* Hct-32.2* 
MCV-89 MCH-30.2 MCHC-34.1 RDW-13.2 Plt ___
___ 12:45PM BLOOD WBC-32.2* RBC-3.63* Hgb-11.0* Hct-32.2* 
MCV-89 MCH-30.2 MCHC-34.1 RDW-13.2 Plt ___
___ 05:00AM BLOOD WBC-15.8*# RBC-3.07* Hgb-9.3* Hct-28.5* 
MCV-93 MCH-30.3 MCHC-32.6 RDW-13.5 Plt ___
___ 07:31AM BLOOD WBC-14.8* RBC-3.28* Hgb-9.8* Hct-29.3* 
MCV-90 MCH-29.9 MCHC-33.4 RDW-13.3 Plt ___
___ 07:57AM BLOOD WBC-8.9 RBC-3.26* Hgb-9.7* Hct-30.2* 
MCV-93 MCH-29.8 MCHC-32.2 RDW-13.4 Plt ___
.
LFT trend
___ 05:00AM BLOOD ALT-53* AST-79* AlkPhos-87 TotBili-0.8
___ 07:31AM BLOOD ALT-65* AST-101* AlkPhos-104 TotBili-0.9
___ 07:57AM BLOOD ALT-44* AST-47* AlkPhos-103 TotBili-0.5
___ 07:25AM BLOOD ALT-34 AST-30 AlkPhos-96 TotBili-0.4
___ 09:00AM BLOOD ALT-44* AST-63* AlkPhos-142* TotBili-0.3
___ 06:17AM BLOOD ALT-43* AST-54* AlkPhos-133* TotBili-0.3
.
Discharge labs:
___ 06:00AM BLOOD WBC-7.7 RBC-3.86* Hgb-11.6* Hct-34.3* 
MCV-89 MCH-30.0 MCHC-33.7 RDW-13.9 Plt ___
___ 06:00AM BLOOD Glucose-85 UreaN-7 Creat-0.8 Na-140 K-4.6 
Cl-101 HCO3-32 AnGap-12
___ 06:17AM BLOOD ALT-43* AST-54* AlkPhos-133* TotBili-0.3
___ 06:00AM BLOOD Calcium-9.1 Phos-5.7* Mg-2.2
.
.
Urine
___ 02:00AM URINE Color-Yellow Appear-Clear Sp ___
___ 02:00AM URINE Blood-NEG Nitrite-NEG Protein-NEG 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG
___ 02:00AM URINE UCG-NEG
___ 05:15PM URINE Color-Red Appear-Hazy Sp ___
___ 05:15PM URINE Blood-LG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-SM
___ 05:15PM URINE RBC->50 WBC-6* Bacteri-NONE Yeast-NONE 
Epi-0
.
.
Microbiology:
___ 11:45 pm BLOOD CULTURE      FROM PICC LINE. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___: 
      STAPHYLOCOCCUS, COAGULASE NEGATIVE.    FINAL 
SENSITIVITIES. 
         Staphylococcus species may develop resistance during 
prolonged
         therapy with quinolones.   Therefore, isolates that are 
initially
         susceptible may become resistant within three to four 
days after
         initiation of therapy.  Testing of repeat isolates may 
be
         warranted. 
      STAPHYLOCOCCUS, COAGULASE NEGATIVE.    SECOND MORPHOLOGY. 
         FINAL SENSITIVITIES. 
         Staphylococcus species may develop resistance during 
prolonged
         therapy with quinolones.   Therefore, isolates that are 
initially
         susceptible may become resistant within three to four 
days after
         initiation of therapy.  Testing of repeat isolates may 
be
         warranted. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STAPHYLOCOCCUS, COAGULASE NEGATIVE
                             |          STAPHYLOCOCCUS, 
COAGULASE NEGATIVE
                             |          |   
CLINDAMYCIN-----------<=0.25 S   <=0.25 S
ERYTHROMYCIN----------<=0.25 S   <=0.25 S
GENTAMICIN------------ <=0.5 S    <=0.5 S
LEVOFLOXACIN----------<=0.12 S   <=0.12 S
OXACILLIN-------------<=0.25 S   <=0.25 S
TETRACYCLINE----------   <=1 S        2 S
VANCOMYCIN------------     1 S        2 S

   Aerobic Bottle Gram Stain (Final ___: 
      GRAM POSITIVE COCCI IN CLUSTERS. 

   Anaerobic Bottle Gram Stain (Final ___: 
      GRAM POSITIVE COCCI IN CLUSTERS. 
.
___ 11:10 am BLOOD CULTURE      SET 1. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___:    NO GROWTH. 
.
___ 11:53 am BLOOD CULTURE      Source: Line-PICC SET 2. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___: 
      STAPHYLOCOCCUS, COAGULASE NEGATIVE.    FINAL 
SENSITIVITIES. 
         Staphylococcus species may develop resistance during 
prolonged
         therapy with quinolones.   Therefore, isolates that are 
initially
         susceptible may become resistant within three to four 
days after
         initiation of therapy.  Testing of repeat isolates may 
be
         warranted. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STAPHYLOCOCCUS, COAGULASE NEGATIVE
                             |   
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------<=0.12 S
OXACILLIN-------------<=0.25 S
TETRACYCLINE----------   <=1 S
VANCOMYCIN------------     1 S

   Aerobic Bottle Gram Stain (Final ___:  
      GRAM POSITIVE COCCI IN CLUSTERS. 
.
___ 7:31 am BLOOD CULTURE      Source: Line-PICC 1 OF 2. 

                            **FINAL REPORT ___

   Blood Culture, Routine (Final ___: 
      STAPHYLOCOCCUS, COAGULASE NEGATIVE.    FINAL 
SENSITIVITIES. 
         Staphylococcus species may develop resistance during 
prolonged
         therapy with quinolones.   Therefore, isolates that are 
initially
         susceptible may become resistant within three to four 
days after
         initiation of therapy.  Testing of repeat isolates may 
be
         warranted. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             STAPHYLOCOCCUS, COAGULASE NEGATIVE
                             |   
CLINDAMYCIN-----------<=0.25 S
ERYTHROMYCIN----------<=0.25 S
GENTAMICIN------------ <=0.5 S
LEVOFLOXACIN----------<=0.12 S
OXACILLIN-------------<=0.25 S
TETRACYCLINE----------   <=1 S
VANCOMYCIN------------     1 S

   Aerobic Bottle Gram Stain (Final ___: 
      GRAM POSITIVE COCCI. 
      IN PAIRS AND CLUSTERS. 
.
BC ___ and ___ negative
BC ___ pending at time of writing
.
___ 10:12 am CATHETER TIP-IV      Source: picc line. 

                            **FINAL REPORT ___

   WOUND CULTURE (Final ___:    No significant growth. 
.
___ 6:00 am STOOL     CONSISTENCY: FORMED      Source: 
Stool. 

                            **FINAL REPORT ___

   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA 
FOUND. 

   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER 
FOUND. 

   OVA + PARASITES (Final ___: 
      NO OVA AND PARASITES SEEN. 
      This test does not reliably detect Cryptosporidium, 
Cyclospora or
      Microsporidium. While most cases of Giardia are detected 
by routine
      O+P, the Giardia antigen test may enhance detection when 
organisms
      are rare. 

   CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: 
      Feces negative for C.difficile toxin A & B by EIA. 
           (Reference Range-Negative). 
.
Further C difficile toxin x3 negative and ova, cysts and 
parasites negative x3
.
___ 5:15 pm URINE      Source: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___:    NO GROWTH. 
.
.
Cardiology:
ECG Study Date of ___  9:03:38 ___ 
 
  
Artifact is present. Sinus rhythm. Non-specific ST-T wave 
changes. No previous 
tracing available for comparison.  
  
 
Read by: ___. 
 
  ___ Axes 
Rate PR QRS QT/QTc P QRS T 
78 142 82 ___ 15 
.
TTE (Complete) Done ___ at 11:27:14 AM      FINAL 
The left atrium is elongated. The estimated right atrial 
pressure is ___ mmHg. Left ventricular wall thickness, cavity 
size and regional/global systolic function are normal (LVEF 
>55%). Right ventricular chamber size and free wall motion are 
normal. The diameters of aorta at the sinus, ascending and arch 
levels are normal. The aortic valve leaflets (3) appear 
structurally normal with good leaflet excursion and no aortic 
regurgitation. No masses or vegetations are seen on the aortic 
valve. The mitral valve appears structurally normal with trivial 
mitral regurgitation. No mass or vegetation is seen on the 
mitral valve. The estimated pulmonary artery systolic pressure 
is normal. No vegetation/mass is seen on the pulmonic valve. 
There is no pericardial effusion. 

IMPRESSION: No vegetations or clinically-significant regurgitant 
valvular disease seen (good-quality study). Normal global and 
regional biventricular systolic function.
.
.
Radiology:
CHEST (PA & LAT) Study Date of ___ 5:34 AM 
FINDINGS: In comparison with study of ___, there is little 
change and no evidence of acute cardiopulmonary disease. No 
pneumonia, vascular congestion, or pleural effusion. The tip of 
the left subclavian catheter is in the mid portion of the SVC. 
.
CT ABD & PELVIS W & W/O CONTRAST, ADDL SECTIONS Study Date of 
___ 5:56 ___ 
FINDINGS:  
  
CT ABDOMEN: 
Inflammatory change with associated gravitational atelectasis 
and 
bronchiolectasis is noted in the lower lobes bilaterally, 
greater on the 
right side. There is a 5-mm nodule identified laterally in the 
right lower 
lobe measuring 5 mm (series 3 image 11) which is likely 
reactive.  
  
No evidence for pneumoperitoneum.  
There is mild intrahepatic biliary dilatation predominantly 
within the right lobe, stable since prior CT in ___. There has 
been prior cholecystectomy.  
The main portal vein is patent. Common bile duct is dilated at 
the head of the pancreas measuring 12 mm (series 3 image 24) 
again stable when compared with prior imaging.  
There has been previous partial pancreatectomy, cholecystectomy 
and splenectomy. Splenule noted in the left upper quadrant. The 
pancreatic duct is uniformly dilated throughout the remainder of 
the pancreas measuring maximum 3 mm. No peripancreatic stranding 
or fluid to suggest active pancreatitis at this time. 
Unremarkable hepaticojejunostomy. The adrenal glands and kidneys 
are unremarkable.  
No retroperitoneal masses or adenopathy. 
  
CT PELVIS:  
The rectum and sigmoid colon are normal. The uterus is normal 
with an endometrial stripe cavity consistent with patient's age. 
No adnexal masses, no pelvic adenopathy or free fluid. No acute 
intra-abdominal abscess identified.  
  
  
CT OSSEOUS SKELETON:  
No osseous destructive lesion. 
  
IMPRESSION:  
  
1. The patient is status post partial pancreatectomy in ___. No 
evidence for acute pancreatitis or abscess.  
  
2. Inflammatory change noted in the right lower lobe 
.
CHEST (PA & LAT) Study Date of ___ 5:18 ___ 
IMPRESSION: PA and lateral chest compared to ___, 
and ___: 
  
Small bilateral pleural effusion is new since ___. Lungs are 
clear.  
Heart size normal. The pulmonary vasculature is more full today 
than it was on the previous study but not pathologically so, and 
mediastinal veins are not dilated. Left PIC line has been 
removed.

 
Brief Hospital Course:
___ woman with a history of chronic pancreatitis. She is 
presenting with symptoms similar to her prior episodes. Found to 
have rising WBC up to 32.2 on ___nd he 
was presumptively treated with IV metronidazole for c difficile 
but patient had no diarrhea and had CT abdomen which showed 
biliary dilatation which was stable. WCC resolved by ___ during 
stay and found to have GPCs on BCs later found to be 
pan-sensitive coagulase -negative staph. Patient was started on 
IV vancomycin ___ and PICC pulled as this was the likely source 
of infection. IV metronidazole was stopped as c difficile toxin 
-negative x3. Patient had a fever ___ to 101.1F and none further 
and no further positive BC with otherwise negative infection 
screen. PICC replaced ___ for home IV antibiotics as normal WCC 
and afebrile. Patient began to start eating and by the day prior 
to discharge was eating solids without significant pain or 
vomiting. Dietitian recommended supplements with Ensure and the 
patient was discharged on ___.
.  
# Chronic Pancreatitis: This was felt to represent on of her 
normal pancreatitis flares with  tender abdomen without guarding 
or rebound tenderness. Patient was treated initially with IV 
dilaudid, IV compazine for mild nausea without vomiting and TPN 
until blood cultures were positive at which point her PICC was 
removed. On the day after admission, her WCC rose to 32.2 and IV 
metronidazole was presumptively started for possible c 
difficile. She proceeded to a CXR which showed no free air and a 
CT which showed stable biliary dilatation and no acute process. 
She had no symptoms and latterly this was felt to be reactive to 
her bacteremia in the setting of asplenism. Her WCC resolved to 
normal after commencing IV vancomycin for her coagulase negative 
staph bacteremia. Patient had a fever of 101.1F on ___ and a 
septic screen was negative. She had no further fevers. Patient 
was eating better ___ and nausea was under control and CXR shows 
tiny effusions and some pulmonary vascular congestion at which 
point IV fluids were stopped and did not require re-institution. 
PICC was inserted ___ after afebrile and normal WCC for home IV 
antibiotics. We tapered down her dilaudid and by ___ was 
tolerating her home oral regimen. Patient was discharged home 
with laxatives on her home dilaudid dose on ___. She was 
reviewed by dietitian who recommended supplementation with 
Ensure which she will purchase. She will see her PCP ___ ___ and 
has a gastroenterology appointment on ___. Her antibiotics will 
finish on ___.
.
# CoNS Bacteremia due to line infection: GPCs in 3 sets of BCs 
from PICC ___ and ___ which grew pan-sensitive coagulase 
negative staphylococci. This was felt likely secondary to a line 
infection in the setting of TPN via her PICC which did not 
appear cellulitic on admission. She remained stable and appeared 
well other than pain throughout her hospital stay. Echo on 
___ was normal with no vegetations. She was started on IV 
vancomycin (due to initial concern for MRSA) on ___ and this was 
continued despite pan-sensitive isolates given preferable dosing 
frequency and previous hemolytic anemia with cephalosporins. 
Patient had a fever of 101.1F on ___ and a septic screen was 
negative. She had no further fevers. PICC was inserted ___ after 
afebrile and normal WCC for home IV antibiotics. She had a low 
vancomycin level on ___ and dose was increased to 1250mg bid 
however she had high levels on this dose of 21.8 and 27.2 (on 
the day of discharge) and her dose was decreased back to 1g bid. 
Pharmacy latterly felt that her vancomycin level may rise given 
the trend on ___ and would consider repeat Chem 7/vancomycin 
level to assess renal function and vancomycin level in light of 
possible vancomycin accumulation. A message was left for her PCP 
who will see her on ___. She was discharged home on ___ and 
her IV vancomycin will continue until ___.
.
# Malnutrition, mod: Patient was initially receiving TPN in the 
community but given PICC line infection her PICC was removed and 
she was started on IV fluids and kept NPO. Outpatient plan was 
to wean TPN in community and trial eating and if failed to 
consider Jej tube placement. Patient slowly advanced her diet 
and by ___ was eating better and nausea was under control. She 
advanced her diet to full regular on ___ and she tolerated this. 
She will trial a normal oral diet in the community but if this 
fails she may have to consider J-tube placement given the fact 
that this is her second PICC line infection. She was seen by 
dietitian on the day of discharge who recommended supplemental 
Ensure which she will purchase.
.
# Constipation: Patient was constipated and we started senna, 
docusate and PRN miralax, lactulose and suppositories which was 
effective. She was informed to continue these as needed in the 
community.
.
# Leukocytosis: WBC rose to 32.2 precipitously on ___. Patient 
had one episode of loose stools on the day prior to admission 
and had none further. There was no colitis on CT to suggest c 
difficile and patient was presumptively treated with IV 
metronidazole which was stopped after the clinical picture was 
not in keeping with this and the first c difficile toxin was 
negative. The leukocytosis resolved and was 7.7 on discharge. 
Leukocytosis was likely reactive given bacteremia and asplenic 
state. 
.
# Elevated LFTs: Developed a new mild transaminitis up to max 
ALT 65 AST 101 with otherwise normal LFTs after commencement of 
antibiotics. Biliary dilatation on CT abdomen was at baseline. 
LFTs fluctuated and one point normalised. Still mild elevation 
on discharge. This was felt likely due to her antibiotics. LFTs 
should be rechecked in 1 week by her PCP in addition to Chem 7 
given IV vancomycin therapy.
.
# Hypothyroidism: We continued home levothyroxine
.
# Depression: We continued citalopram. 
 
Medications on Admission:
1. levothyroxine 150 mcg  
2. fentanyl 100 mcg/hr Patch 72 hr  
3. citalopram 60 mg Tablet  
4. senna 8.6 mg Tablet  
5. Colace 100 mg  
6. hydromorphone 2 mg Tablet Sig: ___ Tablets PO Q4H prn  
7. prochlorperazine maleate 5 -10 mg q 6 
 
Discharge Medications:
1. levothyroxine 75 mcg Tablet Sig: Two (2) Tablet PO DAILY 
(Daily).  
2. fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr 
Transdermal Q72H (every 72 hours).  
3. citalopram 20 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
4. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO DAILY 
(Daily).
Disp:*60 Capsule(s)* Refills:*2*
5. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a 
day).
Disp:*60 Tablet(s)* Refills:*2*
6. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1)  PO 
DAILY (Daily) as needed for constipation.
Disp:*30 * Refills:*0*
7. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO Q8H 
(every 8 hours) as needed for constipation.
Disp:*400 ML(s)* Refills:*0*
8. vancomycin 1,000 mg Recon Soln Sig: One (1) dose Intravenous 
Q 12H (Every 12 Hours) for 8 days: Last day ___.
Disp:*15 dose* Refills:*0*
9. hydromorphone 4 mg Tablet Sig: One (1) Tablet PO every four 
(4) hours as needed for pain.  
10. Outpatient Lab Work
Check Chem7 and LFTs (ALT, AST, Alk P, Bil, Alb) on ___ 
and fax to Dr ___ on ___.

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
Chronic pancreatitis flare
Coagulase negative staphylococcus bacteremia secondary to ___ 
line infection

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
It was a plleasure taking care of you during your stay at the 
___. You presented with a flar 
eof your chronic pancreatitis. You were treated with IV dilaudid 
(hydromorphone) for your pain and anti-nausea drugs for your 
nausea. We also found evidence of a blood infection of your PICC 
line after some bacteria grew on blood cultures taken from your 
line. The infection was causes by a bacteria called a "coagulase 
negative staphylococcus" which is a common organism on your skin 
and for this you were treated with IV vancomycin and your PICC 
line was removed. You had a high white blood cell count which we 
think was due to this bacterial infection. We briefly treated 
you with another antibiotic called metronidazole for possible C 
difficile (a bacterial infection of the gut which causes prifuse 
diarrhea and is generally associated with recent antibiotic use) 
but you were NOT found to have this after tests came back 
negative. Your high white cell count resolved  and was likely 
due to your blood infection. You will continue treatment for 
your blood infection with home IV antibiotic therapy with 
vancomycin until ___. You had a new PICC line placed for 
this. Your pain improved and you were able to be sent home with 
your home dilaudid dose. You were managing solid foods and were 
sent home on a regular diet however if this does not work out 
you may require a jejunostomy tube in the future for feeding. 
You were seen by the dietitian on the day of discharge who 
recommended dietary supplementation with Ensure which you can 
buy at your supermarket.
You have an appointment to see your PCP ___ ___ and your 
gastroenterologist on ___. 
Medication changes:
We STARTED IV vancomycin twice daily which should continue until 
___ and after this yo should have your PICC line removed 
to reduce risk of further infection
We STARTED laxatives for your constipation whcih you should take 
as needed
You were discharged on your previous home dose of dilaudid

You should continue your other medications as previously 
prescribed 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-18 | hadm_id=28880663

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape / Morphine
 
Attending: ___
 
Chief Complaint:
Abdominal pain.
 
Major Surgical or Invasive Procedure:
None

None

 
History of Present Illness:
This is a ___ yo woman with h/o recurrent pancreatitis who p/w 
her typical pancreatitis flare (epigastric abd pain, nausea). 
Attempted liquid diet and PO dilaudid/fentanyl patch at home 
with no improvement so called GI and referred to the ED. She 
notes this seemed to start 4 days prior, after receiving the 
H1N1 vaccine. She denies vomiting despite the nausea, but notes 
eating or drinking causes abdominl pain. The pain is currently 
___, epigastric and bilateral upper quadrants without 
radiation. It is better with resting, worse with movement or 
eating. She has noticed sweats, which is unusual, but denies 
fevers or chills. No change in her BM's, no HA, visual change, 
cough, sob, cp, palpitations, dysuria, rash, ___ swelling. She is 
followed by Dr. ___ pancreatitis but has not seen him 
since ___.

In the ED: VS: 98.4 74 140/75 12 100% on RA. She was given 
dilaudid 1mg x2 and 1L NS. 

ROS: 10 point review of systems negative except as noted above.
 
Past Medical History:
1) Recurrent pancreatitis: Started after partial pancreatectomy 
in ___.  Then no recurrent until ___.  Was hospitalized in 
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
stent placement in panc duct.  Further episodes in ___ 
with same ERCP again and stent extension.  In ___, another bout 
of acute pancreatitis, but ERCP this time showed no duct 
stenosis.  
2) Hemolytic anemia: reaction to Keflex, treated with 
splenectomy in ___.
3) s/p ccy in ___
4) s/p appy in ___
5) Asthma: mild intermittent, uses no meds at baseline
6) hypothyroidism
7) s/p tubal ligation
8) Depression
9) Right UE DVT in the setting of central line, on coumadin 
since ___, per PCP to continue on it at this time
 
Social History:
___
Family History:
Mother with diabetes, osteoporosis, hypertension, 
hypothyroidism, chronic pain.
 
Physical Exam:
On ADMISSION:
VS: T 98.9 HR 70 BP 114/80 RR 18 Sat 100% RA
Gen: Well appearing woman in NAD
Eye: extra-occular movements intact, pupils equal round, 
reactive to light, sclera anicteric, not injected, no exudates
ENT: mucus membranes moist, no ulcerations or exudates
Neck: no thyromegally, JVD: flat
Cardiovascular: regular rate and rhythm, normal s1, s2, no 
murmurs, rubs or gallops
Respiratory: Clear to auscultation bilaterally, no wheezes, 
rales or rhonchi
Abd: Soft, tender to palpation in the epigastric area and 
bilateral upper quadrants without rebound or gaurding, non 
distended, no heptosplenomegally, bowel sounds present
Extremities: No cyanosis, clubbing, edema, joint swelling
Neurological: Alert and oriented x3, CN II-XII intact, normal 
attention, sensation normal, speech fluent
Integument: Warm, moist, no rash or ulceration  
Psychiatric: flat affect
Hematologic: no cervical or supraclavicular LAD
 
Pertinent Results:
Admit labs:
CBC: WBC-9.7 RBC-4.33 HGB-13.2 HCT-39.5 MCV-91 MCH-30.4 
MCHC-33.3 RDW-12.9
PLT COUNT-478; diff: NEUTS-59.0 ___ MONOS-6.4 EOS-2.1 
BASOS-0.7
BMP: GLUCOSE-101* UREA N-10 CREAT-0.8 SODIUM-140 POTASSIUM-4.2 
CHLORIDE-105 TOTAL CO2-27 ANION GAP-12
LFT: ALT(SGPT)-8 AST(SGOT)-20 ALK PHOS-88 TOT BILI-0.6 
LIPASE-63* TOT PROT-7.9
COAGS: ___ PTT-27.1 ___

MRCP ___: 1. Mild intrahepatic and pancreatic ductal 
dilatation, similar to CT appearance from ___, however, 
increased from MRCP ___. Though the changing 
appearance of biliary system is unusual, the dilation of the 
pancreatic and biliary systems without a mass lesion raises the 
possibility of an ampullary stricture. 
2. Small bowel and pancreatic head malrotation. Stable changes 
status post 
distal pancreatectomy. Prompt emptying of the pancreatic duct 
following 
secretin administration. 

 
Brief Hospital Course:
This is a ___ year old female with chronic pancreatitis, who 
presented with abdominal pain consistent with recurent 
pancreatitis.

1. Abdominal pain: Her pain was the same as with prior flares, 
and labs demonstrated a mild elevation of lipase. She was made 
NPO and given IV fluids and IV dilaudid (normally on 4 mg PO at 
home plus a fentanyl patch, which was continued). Of note, she 
is followed by Dr. ___ referred her to the pain clinic for 
consideration of spinal cord stimulator implant, however the 
patient elected not to have the procedure. The patient's diet 
was slowly advanced, and she was able to tolerate PO for ___ 
days prior to discharge.  She will see Dr. ___ in followup as 
an outpatient in ___ weeks.  She was discharged on a small 
number of dilaudid tablets until she sees her PCP ___ ___.  

2. DVT: She was diagnosed with an upper extremity 
catheter-associated DVT during her admission here in ___ and 
had completed more than 6 months of anticoagulation at the time 
of this admission. Her INR was normal and it appeared that she 
hadn't taken her coumadin in quite some time. After discussion 
with her PCP, ___ was formally discontinued.  She 
was continued on prophylaxis heparin SC only while in the 
hospital. 
 
Medications on Admission:
celexa 60mg daily
synthroid ___ daily
prilosec 20mg daily
ativan 0.5mg q6 prn ->very rare use for tremors
coumadin 2.5mg daily except 5mg on ___ daily
colace 100mg daily
senna 1 tab daily
dilaudid 4mg q4 prn -> at baseline ___ times daily, with flares 
up to 6 times daily
fentanyl 100mcg q72 hours
trazadone 100mg qhs prn insomnia
compazine 10mg q6 prn
multivitamin daily
 
Discharge Medications:
1. Citalopram 20 mg Tablet Sig: Three (3) Tablet PO DAILY 
(Daily).  
2. Levothyroxine 137 mcg Tablet Sig: One (1) Tablet PO DAILY 
(Daily).  
3. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) 
Capsule, Delayed Release(E.C.) PO DAILY (Daily).  
4. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 
hours) as needed for anxiety/tremor.  
5. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 
times a day).  
6. Senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a 
day).  
7. Fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr 
Transdermal Q72H (every 72 hours).  
8. Trazodone 100 mg Tablet Sig: One (1) Tablet PO HS (at 
bedtime) as needed for insomnia.  
9. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). 
 
10. Hydromorphone 4 mg Tablet Sig: One (1) Tablet PO Q4H (every 
4 hours) as needed for pain: Please be aware that this 
medication can cause sedation.  Do NOT drive or operate heavy 
machinery while taking this medication.
Disp:*20 Tablet(s)* Refills:*0*
11. Compazine 5 mg Tablet Sig: ___ Tablets PO every six (6) 
hours as needed for nausea.
Disp:*10 Tablet(s)* Refills:*0*

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Chronic pancreatitis
h/o DVT
Depression/anxiety
Hypothyroidism

 
Discharge Condition:
Mental Status:Clear and coherent
Level of Consciousness:Alert and interactive
Activity Status:Ambulatory - Independent

 
Discharge Instructions:
As you know you had a flare of your chronic pancreatitis. We 
were able to get this under control with bowel rest and pain 
medications.  By the time of discharge, you were able to 
tolerate a regular diet for 2 days and take oral pain 
medications.
Please follow-up with your PCP and with Dr. ___ as detailed 
below. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=13339096-DS-19 | hadm_id=29653173

 
Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
Keflex / Demerol / Codeine / Tape ___ / Morphine
 
Attending: ___.
 
Chief Complaint:
Worsening abd pain for one week
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
The patient is a ___ year old female with chronic pancreatitis 
who presents with a flare of her chronic pancreatitis pain which 
she attributes to drinking wine at a celebratory event a few 
days prior to presentation.

Pt reported taht since she was discharged from the last last 
hospitalization on ___ because of the flare of chronic 
pancreatitis, she felt fine although she had chronic mild middle 
abd pain until one week ago when she felt worsening middle abd 
pain after she drank one glass of wine.  The pain was constant 
and dull in nature and slowly build up.  It located in her upper 
middle abd and across her abd like belt and radiated to her 
back, which is exact like her previous episode of chronic 
pancreatitis flare.  Eating could aggravate the pain and leaning 
forward can slightly relieve the pain.  She complained about 
mild nausea with no vomiting.  She denied abd bloating diarrhea. 
 In contrast, she has chronic constipation. Her last BM took 
place two days ago with hard brownish stool.  She denied BRBPR 
or melena.  She denied dysphagia or heartburn.

Regarding her pancreatitis, she is followed by Dr. ___.  She 
received relative extensive work up to search the etiology of 
chronic pancreatitis, including MRCP with Secretin and EUS and 
ERCP.  She also had normal triglycerides, normal Ca, normal LFT, 
and normal CF mutation test.  However, interestingly, she had 
abnormal Ig G4 that raised the concern of autoimmune 
pancreatitis.  She had been treated with prednisone for ___ 
months for autoimmune pancreatitis.  However, reportedly, she 
did not feel better in terms of abd pain.  Prednisone was 
stopped.    

ROS: no fever, chill, rash, numbness, weakness, jaundice, weight 
loss, muscle-joint pain.  no CP, SOB, cough, dysuria, or 
urgency.  
Current VS: 
72, 124/83, RR = 18, 98% on RA 
 
Past Medical History:
1) Recurrent pancreatitis: Started after partial pancreatectomy 
in ___.  Then no recurrent until ___.  Was hospitalized in 
___ for pancreatitis, underwent an ERCP with sphincterotomy and 
stent placement in panc duct.  Further episodes in ___ 
with same ERCP again and stent extension.  In ___, another bout 
of acute pancreatitis, but ERCP this time showed no duct 
stenosis.  
2) Hemolytic anemia: reaction to Keflex, treated with 
splenectomy in ___.
3) s/p ccy in ___
4) s/p appy in ___
5) Asthma: mild intermittent, uses no meds at baseline
6) hypothyroidism
7) s/p tubal ligation
8) Depression
9) Right UE DVT in the setting of central line, on coumadin 
since ___, per PCP to continue on it at this time
 
Social History:
___
Family History:
Mother with diabetes, osteoporosis, hypertension, 
hypothyroidism, chronic pain.
 
Physical Exam:
VS: T 99.8, BP 135/87 P 63, R 18 SaO2 98%
GEN: AOx3, NAD
HEENT:  PERRLA. MMM. no LAD. no JVD. neck supple. 
Cards: RRR S1/S2 normal. no murmurs/gallops/rubs.
Pulm: No dullness to percussion, CTAB no crackles or wheezes
Abd: soft, mild distend, tender in her middle upper abd with ? 
rebound tenderness, BS decreased.
Extremities: wwp, no edema. DPs, PTs 2+.
Skin: no rashes or bruising
Neuro/Psych: CNs II-XII intact. ___ strength in U/L extremities. 
DTRs 2+ ___.  sensation intact to LT, cerebellar fxn intact (FTN, 
HTS). gait WNL. 

 
Pertinent Results:
___ 08:45PM   GLUCOSE-123* UREA N-6 CREAT-0.8 SODIUM-141 
POTASSIUM-4.5 CHLORIDE-104 TOTAL CO2-30 ANION GAP-12
___ 08:45PM   estGFR-Using this
___ 08:45PM   ALT(SGPT)-10 AST(SGOT)-19 LD(LDH)-118 ALK 
PHOS-87 TOT BILI-0.6
___ 08:45PM   LIPASE-44
___ 08:45PM URINE  HOURS-RANDOM
___ 08:45PM URINE  UCG-NEGATIVE
___ 08:45PM   WBC-10.9 RBC-4.28# HGB-12.9# HCT-38.0# MCV-89 
MCH-30.2 MCHC-34.0 RDW-13.1
___ 08:45PM   NEUTS-65.7 ___ MONOS-6.5 EOS-2.9 
BASOS-1.0
___ 08:45PM   PLT COUNT-434
___ 08:45PM URINE  COLOR-Yellow APPEAR-Clear SP ___
___ 08:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 
LEUK-NEG
.

MRCP with secrtein (___):
1. Mild intrahepatic and pancreatic ductal dilatation, similar 
to CT 
appearance from ___, however, increased from MRCP ___. Though the changing appearance of biliary system is 
unusual, the dilation of the pancreatic and biliary systems 
without a mass lesion raises the possibility of an ampullary 
stricture. 
2. Small bowel and pancreatic head malrotation. Stable changes 
status post distal pancreatectomy. Prompt emptying of the 
pancreatic duct following secretin administration. 
.
EUS ___
Pancreas parenchyma and duct showed changes c/w chronic 
pancreatitis.

___ 08:00AM BLOOD WBC-7.7 RBC-3.93* Hgb-11.7* Hct-35.5* 
MCV-90 MCH-29.7 MCHC-33.0 RDW-12.7 Plt ___
___ 08:10AM BLOOD WBC-7.4 RBC-3.72* Hgb-11.4* Hct-33.1* 
MCV-89 MCH-30.6 MCHC-34.5 RDW-13.4 Plt ___
___ 07:45AM BLOOD WBC-7.8 RBC-3.77* Hgb-11.6* Hct-33.7* 
MCV-89 MCH-30.6 MCHC-34.3 RDW-13.3 Plt ___
___ 08:00AM BLOOD Glucose-98 UreaN-8 Creat-0.9 Na-140 K-4.6 
Cl-103 HCO3-29 AnGap-13
___ 07:55AM BLOOD Glucose-137* UreaN-4* Creat-0.8 Na-139 
K-3.8 Cl-104 HCO3-27 AnGap-12
___ 08:35AM BLOOD Glucose-97 UreaN-5* Creat-0.8 Na-141 
K-4.0 Cl-106 HCO3-29 AnGap-10
___ 08:30AM BLOOD Glucose-90 UreaN-4* Creat-0.7 Na-139 
K-4.1 Cl-105 HCO3-27 AnGap-11
___ 07:25AM BLOOD ALT-5 AST-15 AlkPhos-81 Amylase-62 
TotBili-0.5
___ 08:45PM BLOOD ALT-10 AST-19 LD(LDH)-118 AlkPhos-87 
TotBili-0.6
___ 07:25AM BLOOD Lipase-57
___ 08:45PM BLOOD Lipase-44
___ 07:55AM BLOOD Calcium-9.4 Phos-3.8 Mg-2.0
___ 07:10AM BLOOD Phos-4.3
___ 07:25AM BLOOD TSH-72*
___ 08:30AM BLOOD Free T4-0.72*
___ 07:25AM BLOOD ___ * Titer-1:___ssessment/Plan: Pt is a ___ y.o female with h.o recurrent 
pancreatitis, asthma, hypothyroidism who presented with 
epigastric pain c/w prior episodes of pancreatitis.  
.  
#acute on chronic pancreatitis. Pt with extensive w/u in the 
past by GI for etiology. AT one time thought to be due to 
autoimmune pancreatitis. Pt did have ETOH prior to this 
exacerbation which could have been the trigger. Pt reports 
improvement in her symptoms. Her outpatient GI provider was 
emailed by her caregivers. ___ found to be positive, at titer 
1:40, IgG levels normal. She can follow up the significance of 
this, likely none, with her outpatient GI provider. Pt's diet 
was advanced slowly and she was tolerating a regular diet by 
time of discharge. She was given antiemetics and dilaudid for 
pain.  
.
#hypothyroidism-Pt was continued on her outpatient synthyroid. 
TSH elevated. FT4 slightly low at 0.72 but will defer to 
outpatient setting for any medication adjustment so labs and 
symptoms can be appropriately followed.  
.  
#anemia-normocytic-baseline ___. Currently within baseline. 
Prior labs have shown anemia of chronic disease. Pt's HCT 
remained stable and she did not show signs of bleeding. 
.  
#depression-continued celexa.  
.  

 
Medications on Admission:
Baased on OMR (pt could not recall the dose):
celexa 60mg PO daily
Hydromorphone 4 mg  PO Q4hr PRN
Levothyroxine 150 mcg PO daily
Docusate Sodium 100 mg  PO BID 
Senna 8.6 mg Two Tablet PO BID
fentanyl patch 75mcg/hr Q3 days 
 
Discharge Medications:
1. hydromorphone 4 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 
hours) as needed for severe pain: do not drive when taking this 
medication.
Disp:*30 Tablet(s)* Refills:*0*
2. prochlorperazine maleate 5 mg Tablet Sig: ___ Tablets PO 
every ___ hours as needed for nausea.
Disp:*20 Tablet(s)* Refills:*0*

ADvised to continue other home medications as prior to admission
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
acute on chronic pancreatitis
abdominal pain
hypothyroidism
normocytic anemia

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted with abdominal pain that was felt to be 
related to  your pancreatitis. For this, you were given IV 
fluids and medication for pain and nausea. Your symptoms 
improved and you were tolerating a regular diet by discharge.
.
You have a very mild anemia. You should continue to follow up 
with your PCP for monitoring and discuss whether you may need a 
colonoscopy.
.
Your thyroid medication, may need to be adjusted by your primary 
care physician, please keep your scheduled follow up with your 
PCP next week and have your thyroid levels checked.
.
Medication changes:
1.you may take dilaudid for pain. Please do not drive or operate 
heavy machinery when taking this medication. 
2.you may take compazine for nausea.
3.discuss with your PCP whether you need to adjust your 
levothyroxine dosing.

NONE of your other medications were changed. 
.
Please take all of your medications as prescribed and follow up 
with the appointments below.
 
Followup Instructions:
___
